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MAINTENANCE OF NEURON ACTIVITY BY HOMEOSTATIC ALTERATIONS IN
RECEPTORS AND ION CHANNELS IN A RETT SYNDROME MOUSE MODEL

by

MAX F. OGINSKY

Under the Direction of Chun Jiang, PhD

ABSTRACT
Rett Syndrome (RTT) is a developmental disorder that affects numerous
neuronal systems that underlie problems with breathing, movement, cognition and
sleep. RTT is caused by mutations in the methyl-CpG-binding protein 2 (Mecp2)
gene. MeCP2 is a ubiquitous protein that is found in all mature neurons and binds to
methylated DNA to repress transcription; thus regulating protein expression levels in
neurons. The mutations in Mecp2 affect a large number of proteins that are crucial
for regulating neuronal activity. Despite the abnormal expression of many of these
proteins, mice with a total loss of MeCP2 can live to adulthood and some people
with RTT can live to a very late age as well. It is possible that mutations in the
Mecp2 gene not only cause widespread defects, but also elicit neuroadaptive

processes that may limit the impact of the MeCP2 dysfunction. To test this
hypothesis we performed these studies in which we focused on how synaptic and
membrane currents were altered to maintain normal neuronal activity in Mecp2-null
mice. We show two examples from different neurons where neuroadaptations of ion
channel expression allowed the neuron to remain viable. First, the properties of the
nicotinic acetylcholine receptor (nAChR) current were altered in LC neurons in
Mecp2-null mice. This was caused by changes in the nicotinic receptor subunit
expression. Despite the changes in the nAChR current, the cholinergic modulation of
LC neuron activity in WT and Mecp2-null mice were similar. Secondly, we show that
the fast Na+ voltage-gated and the hyperpolarization-activated currents were altered
in mesencephalic trigeminal V (Me5) propriosensory neurons. The changes in the
hyperpolarization-activated current caused a smaller sag and post-inhibitory
rebound. Opposite to what we expected, these cells were hyperexcitable. The
hyperexcitability was due to changes in the fast Na+ voltage-gated current causing a
decreased action potential threshold. Alterations in the ionic currents in Me5 neurons
seem to be due to changes in subunit expression patterns. These results indicate
that despite the complications caused by defects in the Mecp2 gene, neurons
respond by rearranging receptor / ion channel expression. This reorganization allows
neurons to remain viable despite the MeCP2 deficiency.
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1 SPECIFIC AIMS OF THE DISSERTATION
The loss of proper Methyl-CpG-binding protein 2 (MeCP2) function is the
molecular basis of Rett syndrome (RTT). RTT is characterized by abnormalities in
breathing, motor function, cognition and sleep, in addition to other autistic features.
These problems have largely been linked to dysfunction in signaling between neurons
as well as neuronal intrinsic membrane properties. The decrease in GABA and
norepinephrine (NE) signaling has been shown to be associated with breathing
disorders, characteristics of RTT that underlie the high (26%) sudden and unexpected
death rates (Abdala et al. 2010; Viemari et al. 2005). This may be partially due to the
decrease in the expression of the NE -synthesizing enzymes, tyrosine hydroxylase and
dopamine-β- hydroxylase in locus coeruleus (LC) neurons, and the GABA-synthesizing
enzyme glutamic acid decarboxylase in GABAergic neurons (Chao et al. 2010; Zhang et
al. 2010b). Abnormalities in LC neuronal intrinsic membrane properties also contribute
to the defects in breathing (Zhang et al. 2010a; Zhang et al. 2011). The coexistence of
the defects in NE and GABA systems suggest that brainstem neuronal networks are
affected by the Mecp2 disruption, which may involve other neurotransmitter systems
such as serotonin and acetylcholine (ACh) as well. ACh regulates the expression of
enzymes for NE and GABA biosynthesis and may be involved in the problems
associated with the NE and GABAergic systems (Gueorguiev et al. 2000; Maloku et al.
2011). Indeed, ACh signaling has been shown to be defective in RTT (Nag and BergerSweeney 2007; Weng et al. 2011; Wenk and Hauss-Wegrzyniak 1999; Wenk and
Mobley 1996). The NE, GABA and cholinergic systems regulate certain behaviors
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including arousal state and sleep/wake cycles. Experimental evidence suggests that the
modulation of the NE system by GABA is deficient and contributes to neuronal
hyperexcitability. A similar defect may occur in the cholinergic system, a hypothesis that
we have proposed experiments to test.
The involvement of multiple neurotransmitter systems in the development of
RTT-like disorders in Mecp2-null mice suggests that an appropriate regulation of these
neurotransmitter systems is necessary to maintain them in a homeostatic state.
Homeostasis of neurotransmitter systems will not only allow a better control of
neurotransmission, but also enable potential compensatory neuroadaptations to the
defects in receptors and ion channels. The latter may be in action in RTT mouse models
to limit the impact of the loss of MeCP2 function, a novel hypothesis that we have
proposed in these studies.
The homeostatic adaptive mechanism is known to occur in response to genetic
perturbation. In animals with a specific ion channel gene knocked out, neurons alter the
expression of other ion channels to maintain normal function. (Bonin et al. 2013; Kim
and Hoffman 2012; Ortinski et al. 2006). There is evidence for neuroadaptations in
Parkinson’s disease animal models as well (Golden et al. 2013; Lloyd 1977; McCallum
et al. 2006). Therefore, it is possible that similar types of alterations in channel
expression may be occurring in RTT mouse models to maintain normal function.
Despite the belief of its existence, it was unclear how the homeostatic compensatory
mechanism would work. Since RTT affects signaling between neurons, we investigated
the mechanisms for neuronal activity and communication, in which receptors and ionic
channels are known to play an important role.
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To validate the homeostatic neuroadaptation hypothesis, we investigated
receptors and ion channels in two different neuron types, i.e., cholinergic synaptic
currents in LC neurons and membrane ionic currents in mesencephalic trigeminal V
(Me5) neurons. The LC is the center for NE production in the CNS, whereas the Me5
neurons are propriosensory cells that are crucial for coordinated movement. They
function in autonomic regulation and motor behaviors, respectively. These two systems
show the most severe defects in RTT. Therefore, we have proposed studies to address
two specific aims:

Specific Aim 1 (tested in Chapter 5): How does ACh modulate LC neurons
through presynaptic and postsynaptic mechanisms in WT and Mecp2-/Y mice?
NE is deficient in humans with RTT and mouse models (Panayotis et al. 2011;
Zoghbi et al. 1989). This seems to be due to inherent defects and abnormal synaptic
inputs in LC neurons (Jin et al. 2013a; Zhang et al. 2010a; Zhang et al. 2011). ACh has
several functional overlaps with the NE system. ACh is a classical neurotransmitter
involved with many functions in the CNS and peripheral nervous system. It plays a role
in CNS function by regulating attention, memory function, arousal, transitions in sleep
cycles and mood. These behaviors are dysregulated in RTT (Carotenuto et al. 2013;
Maloku et al. 2011; Schaevitz et al. 2012). The loss of MeCP2 function on cholinergic
signaling is unclear. Few have focused on the dysfunction of the cholinergic system
caused by the knockout of the Mecp2 gene. However, it is clear that NE and ACh
regulate similar behaviors. In one example, LC neurons and ACh neurons regulate each
other resulting in alternations between non-REM and REM sleep states. It is unclear,
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however, whether the modulation of LC neurons by ACh is altered in Mecp2-/Y mice.
Therefore, in this study we investigated the cholinergic modulation of LC neurons in
these mice. These experiments may provide insight into how the knockout of the Mecp2
gene alters the expression of nicotinic acetylcholine receptors (nAChR) in LC neurons,
and whether neurons can alter the expression of synaptic receptors to maintain normal
modulation.

Specific Aim 2 (tested in Chapter 6): How does the loss of MeCP2 affect ionic
currents and firing activity in mesencephalic trigeminal V propriosensory
neurons?
Motor dysfunction is a characteristic of RTT, which may result from motor,
extrapyramidal and propriosensory neuron dysfunction. Propriosensory neurons are
important for relaying information to the brain about the position of the limb in space.
This is critically important for coordinated and directed movement such as locomotion
and mastication. Girls with RTT have problems chewing and swallowing which leads to
malnutrition and poor health (Motil et al. 2012). Whereas most work has been focused
on motor neurons to determine the underlying causes of movement problems, little is
known about how the loss of MeCP2 impairs propriosensory function. In these
experiments we took advantage of the presence of Me5 neurons in the brainstem to test
the homeostatic neuroadaptation hypothesis by focusing on ion channels and intrinsic
member properties. The experiments herein test the hypothesis that the Me5 neurons
from Mecp2-/Y mice are dysfunctional due the knockout of the gene. This study provides
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insight into the membrane ionic currents that affect the intrinsic membrane properties of
Me5 neurons in Mecp2-/Y mice.
Taken together, this dissertation addresses the effects of the Mecp2 knockout on
synaptic and membrane ionic currents. It addresses two important questions: 1) how
does the disruption of Mecp2 impair ion channels and receptors? 2) Do neurons
respond to these defects by rearranging other ion channels and receptors to minimize
and compensate for the defects? The NE-ergic system and the Me5 propriosensory
system were chosen as they represent major defective functions in RTT. Ion channels
and receptors were studied in these neurons as they underlie the intrinsic membrane
properties of neurons as well as neuronal communication, both of which are known to
be defective in RTT. Therefore, this dissertation provides evidence that the loss of
proper MeCP2 function affects neuronal communication by changing synaptic
transmission and by altering membrane ionic currents. It is possible that these types of
neuroadaptations may exist in other diseases with a basis in genetic defects.

2

INTRODUCTION

Definition of key concepts
There is growing evidence suggesting the reason that some diseases progress
through different stages, instead of the victims dying quickly, is because neurons are
able to compensate for the problems caused by the disease. Compensation can be
described as a neuroadaptive mechanism by which one attribute is altered to limit the
problems created by a deficiency in another attribute. For example, in Parkinson’s
disease, the decrease in dopamine in the striatum is caused the death of substantia
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nigra pars compacta neurons. The remaining dopaminergic neurons compensate by
increasing their production of dopamine. This is done by increasing expression of
tyrosine hydroxylase, the rate-limiting enzyme for dopamine synthesis (Zigmond et al.
1984). Here, we provide evidence of compensation done by homeostatic reorganization
of receptors and ion channels. The reorganization refers to the increase in one subunit
of the receptor/ion channel family while another is decreased, or vice versa. These
changes in expression seem to be a homeostatic mechanism because it provides a way
for the neuron to remain viable. These concepts provide a basis for understanding how
neurons adapt to perturbation caused by a disease.
Signaling in the CNS is governed by synaptic transmission and neuron
activity
There are two major components that regulate how a neuron communicates to
other neurons. First, the release of neurotransmitters from a presynaptic neuron and the
subsequent binding of the transmitter to its receptor on the postsynaptic neuron has
been widely studied. Secondly, the intrinsic membrane properties of the neuron governs
how it fires action potentials and how the neuron responds to input from presynaptic
neurons. While not a focus of the thesis, electrical synapses are found in a small
number of neurons. These synapses are formed by gap junctions and allow neurons to
communicate by directly passing electrical current from one cell to another. Because
there is no chemical intermediary, the communication is very fast and usually involved
in simple behaviors such as the escape reflex in lobsters and crayfish. Understanding
how these processes underlie normal communication is essential for understanding
neuron signaling problems found in disease.
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Overview of chemical synaptic transmission in the mammalian CNS
The synapse is the basic structure of chemical neurotransmission in the CNS.
The synapse consists of a presynaptic neuron that releases transmitters and a
postsynaptic neuron that has ligand-gated receptors that convert the chemical message
into an electrical signal. Depending on whether the electrical signal is made up of
cations or anions, the neuron becomes excited or inhibited.
The synaptic communication between two neurons is modified by modulatory
inputs. These inputs can change the amount of neurotransmitter released at the
presynaptic terminal (Garcia-Ramirez et al. 2014). The modulatory inputs can influence
the movement of receptors in and out of the synapse in the postsynaptic neuron (Gao et
al. 2006; Zou et al. 2005). These mechanisms are involved with increasing or
decreasing the synaptic strength and ultimately are thought to underlie compensatory
neuroadaptations such as long term potentiation (LTP) and long term depression (LTD)
(Bassani et al. 2013; Castillo 2012) .
It is unclear how certain genetic diseases that affect signaling between neurons
affect these normal neuromodulatory processes. Experimental evidence from transgenic
animals indicate that the defect in a given gene produces a phenotype that lacks
function (Drago et al. 2003). Whereas in other animals, molecular and systemic
compensation occurs by activating other gene(s) that have similar functions, reducing
and in some cases even masking the defect (Bonin et al. 2013). Evolutionarily, it is
reasonable to believe that compensatory neuroadaptations are necessary for survival or
preservation of a biological system when a crucial gene is mutated.

8`

The transcription repressor protein, methyl-CpG-binding protein 2 (Mecp2) plays
a role in the expression of enzymes crucial for the synthesis of neurotransmitters
(Maloku et al. 2011). As a result, its defect can affect a large number of downstream
genes including several neurotransmitter systems (Chao et al. 2010; Zhang et al.
2010b). In this thesis we elucidate some of the effects that the loss of functioning
MeCP2 has on neuronal activity.
Presynaptic mechanisms of neurotransmitter release
The release of neurotransmitters from a nerve terminal occurs through action
potential dependent and action potential independent mechanisms. The action potential
induced release of neurotransmitters from a presynaptic terminal involves many events
to occur in a choreographed manner. The invasion of the action potential into the
presynaptic terminal causes local depolarization and opening of voltage-gated Ca2+
channels. The influx of Ca2+ into the cell is critical for neurotransmitter release and
blocking of these channels or reducing extracellular Ca2+ prevents the release of the
transmitters. Further, even when the action potential is blocked with tetrodotoxin,
neurotransmitter release at the presynaptic terminal can occur. Depolarization of the
membrane potential at the presynaptic terminal, without the influence from an action
potential, can activate Ca2+ channels (Nakamura and Jang 2010; Yang et al. 2011).
Therefore, action potential independent mechanisms are in place to regulate the release
of neurotransmitters.
Ca2+ binds to molecular targets in the terminal causing the release of
neurotransmitters into the synapse. The vesicles that store the neurotransmitter at the
terminal present at the active zone or site of release. Ca2+ entry causes these vesicles
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to fuse to the membrane and release the neurotransmitters into the synapse (Sudhof
2012). However, since some neurons can respond to stimuli by firing at > 200Hz, it is
important to know how this is possible. Vesicles are tethered and stored in
compartments that are distant from the active zone. Ca2+ binds to synapsin, a protein
that tethers the vesicles, and initiates the vesicle movement to the active zone (Kile et
al. 2010).
Neurotransmitters are released as discrete units called quanta. Each quantum
results in a fixed postsynaptic potential. A single quantum has been linked to the
release of neurotransmitters in a single vesicle. After the action potential invades the
terminal, many quanta are released at once and can affect the membrane potential of
the postsynaptic neuron. However, the release of neurotransmitters independent of an
action potential can be modulated by other inputs at the presynaptic terminal.
Acetylcholine alters the amount of GABA and glutamate released at terminals by
depolarizing the membrane potential. This causes an increase in the frequency of
quanta release. Therefore, increasing the quanta release enhances the effect the
presynaptic neuron has on the postsynaptic neuron.
Postsynaptic mechanisms mediating the chemical message
The ligand-gated ionotropic receptors found in the postsynaptic membrane are
the most common mode of converting the chemical signal from the presynaptic neuron
to an electrical signal in the postsynaptic neuron. In the mammalian CNS, glutamate
mediates the excitatory signal by binding to NMDA and AMPA receptors in the
postsynaptic membrane. Opening of these receptors allows Na+ and Ca2+ to enter and
depolarize the cell. GABA mediates the inhibitory signal by binding to GABAA receptors

10`

causing Cl- to pass into the cell. Also, GABA may bind to GABAB receptors and initiate a
second messenger cascade resulting in activation of K+ currents. In both instances,
GABA can hyperpolarize the cell. Another class of signaling molecule is acetylcholine
(ACh), which is most commonly associated with signaling between motoneurons and
muscles in the peripheral nervous system. In the CNS, ACh acts through the ionotropic
nicotinic acetylcholine receptors (nAChRs) and muscarinic acetylcholine receptors and
is involved with diverse behaviors such as attention, cognition, sleep as well as others
(Romanelli et al. 2007).
Glutamate, GABA and ACh elicit postsynaptic currents that affect the firing
activity of the postsynaptic neuron. Since NMDA, AMPA and nicotinic acetylcholine
receptors allow Na+ and Ca2+ into the cell, the cell depolarizes increasing the likelihood
of an action potential and increasing the firing frequency. GABA- elicited inhibition
through GABAA receptors is caused by Cl- moving into the cell causing the membrane
potential to become hyperpolarized. Hyperpolarization of the membrane potential
increases the likelihood of the cell to be silent or at least reduce the firing frequency.
The activation of these receptors will affect the firing activity of neurons by directly
altering the membrane potential
Long-term potentiation (LTP) Long-term Depression (LTD) are the major
mechanisms of changing the synaptic strength in the CNS. Most often these
mechanisms are associated with excitatory synapses but have been found at inhibitory
synapses as well (Arendt et al. 2013; Cohen et al. 1999; Nugent and Kauer 2008). Preand postsynaptic mechanisms have been described. In brief, the presynaptic
mechanisms involve the increase of neurotransmitter release in LTP and a decrease in
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LTD. Postsynaptically, the ligand-gated receptors move into the synapse during LTP
and are removed during LTD. Many methods have been used to stimulate LTP and
LTD, whether its high/low frequency stimulation of the presynaptic neuron (Martin et al.
2013; Mizuno et al. 2001) or coincidental firing of an action potential between the pre
and postsynaptic neurons (Banerjee et al. 2014; Kodangattil et al. 2013). LTP and LTD
are important for normal cognitive function the brain and disruption of these
mechanisms because of disease leads to improper communication between neurons
(Han et al. 2014; Liu et al. 2008; Mori et al. 2014). This suggests people with diseases
that have altered signaling processes in neurons have impaired learning and memory.
Intrinsic membrane ionic currents affect neuronal activity
Besides synaptic transmission, the intrinsic membrane properties of neurons
governs their firing properties. These intrinsic membrane properties have been
extensively studied and can be generally attributed to specific ionic membrane currents.
Here, we will introduce specific firing properties in the neurons studied and how these
properties affect signaling and function.
The relationship between the injected current and the voltage response of the
neuron is very important for understanding the input resistance of the neuron. The input
resistance is a good measure of the number of channels that are either open or closed
in the membrane of the neuron (John and Manchanda 2011). More specifically, it is a
valuable tool in determining how a drug may affect the membrane ion channels thus
altering the activity of the neuron (Podda et al. 2010). Consequently, the opening and
closing of ion channels alters the excitability of neurons. According to Ohm’s law, the
input resistance has a large effect on membrane potential. If the input resistance is
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large, a current injection is going to change the membrane potential more than if the
input resistance is small. Therefore, membrane ion channels alter the response of the
postsynaptic neuron to presynaptic currents by changing the input resistance of the
neuron.
The delayed excitation found in many neurons affects the interspike interval. The
time it takes from the end of one action potential to the start of the next is regulated by
subthreshold currents. A major contributor to the interspike interval is the fast-transient
K+ current (IA) (McDermott and Schrader 2011). This current is mediated by Kv(4.1-4.3)
channels in mammals and is inactivated during an action potential. Kv4 channels
become deinactivated at subthreshold potentials and activate during the interspike
interval allowing K+ to flow out of the cell. The movement of K+ out of the cell causes the
depolarization of the cell toward threshold to take longer than it would if IA was not
present. Therefore, this particular K+ current regulates the interspike interval and allows
cells to spontaneously fire action potentials at low frequencies.
The post-inhibitory rebound (PIR) is very important to how neurons respond to
the release from inhibition. The phenomenon is very important in half-center oscillators
found in central pattern generators and in reciprocal inhibition found in locomotion. In
both cases, the firing of one neuron causes a second neuron to be inhibited from firing
(Harris-Warrick et al. 1995). When the first neuron stops firing action potentials, the
second neuron rebounds from silence and fires action potentials. Without the PIR, the
neuron would just return to its resting membrane potential without firing an action
potential. Therefore, the PIR depolarizes the neuron past its resting membrane potential
to threshold.
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The underlying mechanism for the PIR has been attributed to the
hyperpolarization- activated current (IH) (Ascoli et al. 2010). IH is a nonspecific cation
current that depolarizes the cell after it has been inhibited. The removal of the inhibition
happens much faster than the deactivation of the HCN channels. This allows cations to
keep moving into the cell driving the voltage past the resting membrane potential to
threshold (Dean et al. 1989).
The spike frequency adaptation (SFA) is a phenomenon that describes how
neurons respond to a sustained depolarizing pulse. When a neuron is subjected to a
depolarizing pulse, a train of action potentials will be elicited. If the SFA is present, then
the frequency of action potentials will decrease during the time of depolarizing pulse
(Chen et al. 2014). This is found in both sensory and motor neurons and has been
related to different mechanisms. The most prominent is the action potential-dependent
SFA. In this case, Ca2+ is brought into the cell during the action potential and Ca2+dependent K+ currents (IKCa) are activated. The activation of these currents increases
the afterhyperpolarization (AHP). The larger AHP slows the depolarization of the
membrane potential. With each successive action potential, the net concentration of
Ca2+ in the cell grows, thus activating more and more KCa channels (Vandael et al.
2012). Therefore, the interspike interval becomes longer during the depolarizing pulse.
This is how the neuron is able to accommodate to the depolarization and slow the
action potential frequency.
Overview of K+ currents role in neuronal activity
Two of the most important functions performed by K+ currents in neurons is the
setting of the resting membrane potential, the repolarization of the action potential and
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the interspike interval. The resting membrane potential is mainly set by K+ leak currents
mediated by TWIK-related acid sensitive K+ (TASK) and Kir channels (Butt and Kalsi
2006). These channels are not voltage or ligand-gated. The conductance of K+ obeys
Ohm’s law. Consequently, the driving force created by the concentration gradient of K+
and the membrane potential of the neuron causes K+ to move out of the neuron. For
most cells, the resting membrane potential is very near the equilibrium potential of the
K+ leak current. When the cell is hyperpolarized below the K+ equilibrium potential the
polyamine block is removed and the channels conduct K+ into the cell. Usually if IKir
plays a large role in setting the resting membrane potential, the potential is usually near
the K+ reversal potential.
The delayed rectifier K+ current (IK) repolarizes neurons during the action
potential. IK activates slowly so that it only influences the membrane potential after the
voltage-gated Na+ current (INa) is inactivated. With no inactivation gate, once the
membrane potential becomes hyperpolarized, the driving force for K+ movement is lost
and thus stops conducting K+. As mentioned before, IKCa regulates spike frequency
adaptation. This is accomplished by its regulation of the AHP of the action potential.
With the exception of the IKCa mediated by SK channels, IKCa is voltage-activated and
modulated by Ca2+. Just as increasing the voltage increases the K+ conductance, so
does increasing the Ca2+. There are three main channel types, BK, IK and SK that
possess different conductance values and Ca2+ dependences (Vergara et al. 1998).
Whereas the BK channel has a voltage dependence independent of Ca2+, the IK and
SK channels have a relatively low voltage-dependence and rely on Ca2+ to be activated.

15`

Therefore, these channels have a different effect on the afterhyperpolarization and
consequently different SFA characteristics.
IA is a subthreshold K+ current that opposes the depolarization of the membrane
potential thus affecting a neuron’s response to presynaptic signaling. This current is
interesting because a hyperpolarized membrane potential deinactivates the channel.
Then when the membrane potential is quickly depolarized, the activation gate opens
allowing K+ to flow out of the cell. The current ceases when the inactivation gate closes
which happens quickly giving the current its transient characteristic. These channels are
located in the somatodendritic compartment of neurons and their intrinsic gating
mechanisms make them suitable to regulate signaling between the dendrites and the
soma (Johnston et al. 2000). For many cells, IA acts as a shunting mechanism to limit
the propagation of postsynaptic potentials to the soma. Therefore, it regulates how
much presynaptic neurons affect the firing of the postsynaptic neuron. Another way that
the expression of these channels affects neuronal communication is in coincidence
detection. The back-propagation of action potentials in the postsynaptic neuron is
necessary for spike timing-dependent LTP. Since IA acts as a shunt, it can limit the
back-propagation of action potentials (Harnett et al. 2013) thus limiting the coincidence
detection that occurs to induce LTP (Ramakers and Storm 2002).
In sum, K+ currents are vital to normal neuronal activity. Not only do they affect
the intrinsic membrane properties during and in between action potentials, but also
signaling between neurons as well. Therefore, the expression levels of the K+ channels
in neurons has an immense impact on firing activity.
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Role of IH in neuron firing properties
As mentioned before, IH is responsible for the PIR found in many neurons. IH is a
nonselective cation current that conducts mostly Na+, but also some K+, when it is
activated by hyperpolarization. This results in the depolarization of the membrane
potential back towards the threshold. Not only is this property of the channel critical in
half-center oscillators and locomotion, but also in pacemaking of neuronal activity,
setting the resting membrane potential and integration of excitatory postsynaptic
currents (Altomare et al. 2003; He et al. 2014).
IH has been well-studied in heart myocytes and contributes to the pacemaking of
the cells (Baruscotti et al. 2005). Just as IA opposed the depolarization of the membrane
potential in between action potentials to make the interspike interval longer, I H enhances
the depolarization of the membrane potential to decrease the interspike interval. IH plays
a large role in setting the interval and it is because of this it is considered a pacemaker
current (Deng et al. 2014). When IA and IH are both present, both contribute to the
interspike interval and can coregulate the interval.
IH is mediated by hyperpolarization and cyclic nucleotide-activated (HCN)
channels. Depending on which HCN channels are expressed, the half-activation may be
anywhere from -70mV to -110mV. Therefore, they do contribute to the setting of the
resting membrane potential. Further, when IH is blocked by its specific blocker, ZD7288,
the resting membrane potential becomes hyperpolarized.
Similar to IA, IH has the ability to affect the propagation of EPSPs from the
dendrites to the soma. Since HCN channels are partially activated at the resting
membrane potential, they decrease the input resistance of the cell. Therefore, the signal
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is much larger in the distal dendrites and much smaller in the proximal dendrites.
Depending on how the HCN channels are expressed in the dendrites they affect how
postsynaptic potentials propagate to the soma (Rusznak et al. 2013).
Voltage-gated Na+ channels are crucial for action potential generation
The voltage-gated Na+ current (INa) is required for the fast depolarization phase
of the action potential. INa is a transient current that depolarizes the cell toward the Na+
equilibrium potential. Functional Na+ channels contain one α pore-forming subunit and
two β auxiliary subunits. The α subunit consists of SCN(1-9)A and the β consists of
SCN(1-4)B gene transcripts (Aman et al. 2009). The threshold of the action potential is,
at least partially, regulated by subunits expressed in the neuron. Regulation of the
threshold ultimately affects the excitability of the neuron. With a lower threshold, less
contribution of depolarizing subthreshold currents is required to fire an action potential.
The Na+ channels that mediate INa are mainly expressed in the axonal
compartment. Therefore, when the action potential is initiated in the axon hillock, the
signal can be propagated down the axon to the terminal, thus initiating the release of
neurotransmitters. The propagation of the action potential is a series of electrical selfstimulation. The movement of Na+ into the cell depolarizes the local area of the
membrane. This depolarization of the membrane causes the Na+ channels to open next
to it and the process repeats itself allowing the movement of the signal down the axon
to the terminal.
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Membrane ionic current regulation of mesencephalic trigeminal V neuron
activity
Mesencephalic trigeminal V (Me5) neurons are propriosensory neurons that
monitor the stretch and tension of jaw masseter muscles thus sending critical
information to the motor neurons needed for coordinated movement. These neurons are
the only propriosensory neurons that are located in the CNS. Most propriosensory
neurons are located in the dorsal root ganglia. Me5 neurons receive signals from the
muscle spindles and relay the information of the limb placement to the motor neurons
(Hidaka et al. 1999; Luo et al. 2001). This controls movement of the limb by
communicating with the inhibitory neurons innervating the muscles that control the
antagonizing muscle.
The membrane currents found in the Me5 neurons are important for their
response to stimuli from the jaw and synaptic inputs from cortical areas. The voltagegated K+ currents that are sensitive to tetraethylammonium (TEA) and 4-aminopyridine
(4-AP) play a role in how the neuron responds to stimuli. Depending on the resting
membrane potential at the time of depolarization, these neurons respond with either
single action potentials or multiple action potentials (Del Negro and Chandler 1997).
Blocking the current with 4-AP, caused the cells to respond to depolarization with only
multiple action potentials. Therefore, the K+ currents do play a role in Me5 neuron
excitability.
A clear response of the Me5 neurons to a hyperpolarizing current injection is a
strong sag and PIR. The sag is a depolarization of the membrane potential despite a
sustained hyperpolarizing pulse. As stated before, the major contributor responsible for
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the sag is IH. The deactivation of IH after the hyperpolarizing current injection is
responsible for the PIR. Also, the presence of HCN channels provides a basis for
dendritic integration and postsynaptic potential propagation to the soma. Since Me5
neurons receive input from muscle spindle fibers and synaptic inputs, I H may play a
large role with how Me5 neurons respond to stimuli.
There are several types of Na+ currents in the Me5 neurons. Besides INa that
controls the action potential initiation and propagation, there are the persistent Na+
current (INaP) and the resurgent current (INaR) (Enomoto et al. 2007). Unlike, INa that
inactivates very quickly, INaP does not inactivate. INaP induces bursting in these neurons
and regulates resonance properties (Enomoto et al. 2006). INaR is much less studied
than INa and INaP. INaR is a subthreshold current that is activated during repolarization but
still is quickly inactivated. Studies indicate that INaR plays a role in spontaneous firing in
neurons and multipeaked action potentials (Raman and Bean 1997).
Brainstem circuitry underlying autonomic behaviors
LC-ACh-GABA brainstem circuit
Within the dorsal pons of the brainstem near the lateral edge of the 4th ventricle is
the locus coeruleus (LC). These neurons produce about 95% of the entire
norepinephrine (NE) in the mammalian brain. NE has been shown to be involved with
learning and memory, proper sleep, pain analgesia, breathing and attention (Brightwell
and Taylor 2009; Doi and Ramirez 2008; O'Donnell et al. 2012). Therefore, the proper
activity of LC neurons is very important to the maintenance of NE in the brain, thus
keeping function and behavior normal.
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The relationship between LC neurons and ACh neurons in the brainstem is very
important for the transitions between rapid eye movement (REM) sleep and non-REM
sleep. During REM sleep cholinergic neurons are very active. ACh is able to suppress
the firing of LC neurons. Eventually, cholinergic neuron activity is decreased and LC
neurons are able to start firing more causing the transition to a non-REM state during
sleep.
GABAergic neurons are the main inhibitory neurons in the mammalian CNS.
These neurons regulate neuronal excitability through synaptic transmission and through
tonic release of GABA. During the transition from non-REM to REM sleep, cholinergic
neurons excite GABAergic neurons which in turn silence the LC neurons through
GABAA receptor- mediated synaptic transmission. GABAA receptors also mediate the
tonic inhibition in the LC (Kawahara et al. 1999) which has been shown to be mediated
by the Δ (Ye et al. 2013), α5 (Groen et al. 2014) and Θ subunits in other brain regions.
Throughout the brain, GABAergic neurons play many roles by regulating neuronal
activity. Within the brainstem, there are areas that regulate the neurons that are
involved with breathing, pain analgesia, cranial motoneuron activity and heart rate.
Besides these behaviors, GABAergic neurons from the forebrain send projections to the
LC nucleus. This is important because NE plays a role in all of these behaviors.
GABAergic neurons projecting from the central amygdala and the posterior lateral
hypothalamic area seem to synapse on LC neurons at the dendrites (i.e., in the peri-LC
region) (Dimitrov et al. 2013). Much less enter into the LC proper. Lastly, there is a local
group of GABAergic neurons near the LC. These neurons are located in the peri-LC
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region with many in the dendritic field (Aston-Jones et al. 2004). These neurons may be
important for integrating information from afferents.
Neuronal activity during autonomic behavior
The autonomic system is involved in regulating involuntary behaviors such as
breathing, body temperature and heart rate. NE, ACh and GABA have all shown to play
a role in breathing. These neurotransmitters modulate the activity of pre-Bötzinger
complex (PBC) neurons in the medulla oblongata (Doi and Ramirez 2008). PBC
neurons are considered the center for breathing rhythmogenesis because the bursting
of these neurons consistently corresponds to extracellular recordings of activity from the
phrenic, vagus and hypoglossal nerves. All of which are involved in breathing but not
rhythmogenesis.
NE, ACh and GABA affect the activity of PBC neurons. LC neurons fire tonically
and the interspike interval seems to be related to the breathing rate (Zhang et al. 2011).
Indeed, disruption in LC activity alters breathing. NE alters the activity of PBC neurons
through two different mechanisms. First, the activation of α2 noradrenergic receptors is
required for cadmium-insensitive bursting PBC neurons (Viemari et al. 2011). Second
the activation of β-noradrenergic receptors increases the frequency of sighs during
breathing. Further, NE modulation through β-noradrenergic receptors increases the
frequency in PBC neurons by modulating INaP (Viemari et al. 2013). GABAergic neurons
play a vital role in breathing as well. Blocking GABAA receptors increases the frequency
and amplitude of the activity recorded from phrenic and hypoglossal nerves (Bongianni
et al. 2010; Shao and Feldman 1997). This suggests that there is a baseline inhibitory
input to the PBC which can be altered to regulate their firing properties. ACh is another
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neurotransmitter that affects PBC activity and breathing. Activation of muscarinic
receptors in the PBC leads to an increase in breathing frequency (Muere et al. 2013). It
also decreases the normal PBC activity and increases the amount of sigh-causing
bursts (Tryba et al. 2008).
It is clear that NE plays a large role in modulating breathing. Since about 95% of
NE is produce in LC neurons, the modulation of LC activity by GABA and ACh is
important. The majority of the GABA input to the LC is mediated by GABAA receptors.
Indeed, GABAA agonists reduce the firing frequency, decrease input resistance and
hyperpolarize the membrane potential in LC neurons (Jin et al. 2013a). Cholinergic
modulation of LC activity has been shown to be mediated by nicotinic acetylcholine
receptors (nAChR) (Cucchiaro et al. 2006; Ganesh et al. 2008). However, the activation
of muscarinic receptors increases LC activity as well (Ennis and Shipley 1992; Yang et
al. 2000). Our preliminary experiments showed that most of the cholinergic modulation
of the increase in LC firing frequency was mediated by the nAChRs. Therefore, we
studied how ACh modulates LC activity both through nAChRs postsynaptically and
presynaptically at GABAergic neurons.
Expression of nAChRs in LC neurons
nAChRs are ligand-gated ion channels that are ionotropic receptors. In
mammals, the nAChRs are found in the peripheral nervous system as well as the CNS.
Each receptor is made up of five subunits with each subunit having four transmembrane
domains. In the CNS of mammalian systems, two types of subunits (α and β) are
expressed: α2-α7, α9-α10 and β2-β4 (Gotti et al. 2005). These eleven subunits can
form a functional receptor with many different combinations of subunits. Further, many
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subunits come together to form heteromeric receptors with the most prevalent
consisting of α4β2 and α6β4 in the mammalian brain or they can be homomeric with
most abundant channel being the α7 (Alkondon et al. 1997; Garduno et al. 2012; Yang
et al. 2011). However, it is possible for the α9 receptor to form homomeric channels, but
much of the time it is expressed with the α10 subunit (Boffi et al. 2013). The nAChR
channel opens when two (in heteromers) or five molecules (in homomers) of
acetylcholine (ACh) binds to the receptors allowing Na+ to flow into the cell. In some
cases, certain receptors may be more permeable to Ca2+. The major effect of the
nAChR activation on the cell is the depolarization of the membrane by the movement of
cations into the cell. However, the Ca2+-permeable receptors such as the α7, may also
induce second messenger systems that affect various cellular processes (Gueorguiev et
al. 2000; Nordman et al. 2014).
The LC has been shown to have many types of nAChR subunits expressed.
Using immunohistochemistry (IHC), the α3, α4, α7 and β3 subunits were found
throughout the LC nucleus suggesting these receptors play a strong role in cholinergic
modulation of LC activity (Vincler and Eisenach 2003). To a much lesser extent, the α5,
β2 and β4 were expressed as well but mostly in the dorsal portion of the LC. Also, it has
been shown that the expression of nAChRs in the LC may be based on different cells
within the nucleus (Lena et al. 1999). In rats, larger LC cells (capacitance > 65pF) had a
larger response to cytisine, a nAChR agonist, than smaller LC cells (capacitance
<45pF) suggesting differential expression of nAChRs. Indeed, single cell PCR showed
that the larger cells showed a preference for expressing α6 and β3 whereas the smaller
cells expressed α3 and β4 (Lena et al. 1999). It should be noted that both cell types
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expressed other receptors but without the consistency of the ones mentioned. There is
a wide diversity of nAChRs expressed in the LC. Based on IHC and electrophysiological
data, LC activity should be significantly modulated by nAChRs.
Rett Syndrome
History
Rett Syndrome (RTT) was first described by Dr. Andreas Rett in 1966 and later
by Dr. Bengt Hagberg (Hagberg et al. 1983). Hagberg was unaware of Rett’s findings
because they were published in German. Nonetheless, from the early findings of Rett to
the later evidence provided by Hagberg, RTT was recognized as a major
neurodevelopmental disorder. Until the 1983 publication by Hagberg, many physicians
in the United States were unaware of the disease. As interest grew in determining the
underlying causes of the disease, the Baylor Rett Syndrome clinic was established.
The Zogbhi lab at Baylor determined that mutations in the MECP2 gene underlies the
problems found in RTT (Amir et al. 1999). Since this discovery, mouse models have
been developed to study the consequences of the loss of proper MeCP2 function in an
attempt to find a cure for the disease.
Progression and symptoms of RTT
RTT is neurodevelopmental disorder meaning it occurs through a progression of
stages that can be clearly delineated by physicians during clinical exams. Normal
development occurs for the first 6 months of life. In stage I, from 6 months to 1.5 years,
the onset begins characterized by a stagnation of development in language and
behavior skills. Stage II is usually defined by a regression of development and starts
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between 1 and 4 years of age. The loss of communication skills and symptoms of
mental retardation are evident as well. Many times during stage III, which can last up to
many years, there is a period of the reacquiring of communication skills. By the onset of
stage IV, patients lose the ability to walk and usually need wheelchairs for mobility. This
last stage can last up to decades. In some of the less severe cases, women can live up
to fifty years of age.
Mutations in the MECP2 gene underlies RTT
As mentioned above, mutations in the MECP2 gene underlies RTT. There have
been about 600 mutations detected in the MECP2 gene. Most of these result in
missense and nonsense mutants. Also, variations in the 5’ UTR and 3’ UTR, intron
variations, insertions and deletions have been found. However, most of the mutations
are found among exons 3 and 4. Further, most of the well-known mutations found in
RTT are found in the methyl-CpG- binding domain and the transcriptional repression
domain.
Random X-inactivation is a process that silences one of the 2 chromosomes
found in females to avoid having twice the amount of proteins created than are found in
males which only have one X chromosome. The designation of which X chromosome
will be inactivated is random in mammals resulting in not only being inactive for the
entirety of the cell’s life but also to all its descendants as well. The inactivation is
accomplished by condensing the X chromosome into heterochromatin that has structure
in such a way that it is unable to be transcribed. Since most of the girls with RTT are
heterozygous for the mutations in the Mecp2 gene, the random X-inactivation plays a
large role in the phenotype of the disease. Therefore, in RTT depending on which X
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chromosome is inactivated and in which cell type, the inactivation has a large effect on
the severity and variety of symptoms.
NE deficiencies contribute to RTT symptoms
The reduction in NE is a hallmark of RTT. NE metabolites were diminished in
cerebrospinal fluid in RTT victims (Zoghbi et al. 1989; Zoghbi et al. 1985). In Mecp2-/Y
mouse models, NE reductions were seen at 14 days and 1 month after birth (Ide et al.
2005; Viemari et al. 2005). These reductions have been associated with breathing
problems. The use of desipramine, a NE reuptake blocker, has been used to reduce
breathing problems in Mecp2-/Y mice (Roux et al. 2007; Zanella et al. 2008; Zhang et al.
2011) . These data indicate that NE signaling is important for proper breathing.
The locus coeruleus (LC) provides about 95% of the norepinephrine to the brain.
Therefore, disruption in the normal function of neurons from this nucleus can have
adverse effects throughout the brain. We have shown in the Jiang lab that LC neurons
from Mecp2-/Y mice are hyperexcitable, smaller in size than WT, have a lower action
potential threshold and increased input resistance (Zhang et al. 2010a). The
norepinephrine synthesizing enzymes tyrosine hydroxylase (TH) and dopamine-βhydroxylase (DBH) are expressed much less in Mecp2-/Y mice (Zhang et al. 2010b). This
indicates that the activity of LC neurons and subsequent release of NE are deficient in
Mecp2-/Y mice. LC neurons are chemosensory neurons. This is thought to occur
primarily by the sensing of pH by Kir channels. The ability of LC neurons to sense
changes in pH is defective in Mecp2-/Y mice. This has been attributed to alterations in
the expression of Kir channels (Zhang et al. 2011). Therefore, the chemosensory input
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from the LC may be defective and likely due to insufficient NE release in the preBötzinger complex, neurons thought to initiate breathing.
The GABA system is defective in RTT. Low GABA has been shown in
cerebrospinal fluid of RTT patients (Perry et al. 1988). Also, there is an increase in
GABA receptor expression in the basal ganglia of RTT victims (Blue et al. 1999). In
Mecp2-/Y mice, GABA signaling is reduced in these mice and has been attributed to low
glutamic acid decarboxylase (GAD) expression (Medrihan et al. 2008). The GABA
modulation of LC neurons in Mecp2-/Y mice is defective as well. The GABAB receptormediated reduction in the Kir current in Mecp2-/Y mice is defective and the mIPSC
frequency and amplitude are reduced (Jin et al. 2013a). These defects seem to account
for the decreased inhibition of LC firing activity in Mecp2-/Y mice. Further, the
allopregnanolone modulation of GABAA receptor currents is defective which contribute
to the hyperexcitability of LC neurons in Mecp2-/Y mice.
Motor system deficiencies underlie RTT symptoms
The most common feature of RTT investigated has been defects in breathing.
However, the motor problems in RTT have received much less attention. These girls
with RTT develop normally but the earliest symptoms involve the loss of muscle tone.
Eventually, these girls have difficulties with coordinated and purposeful hand
movements including a stereotypical hand-wringing movement or they place their hands
in their mouths. As these girls become older, their posture is compromised and walking
becomes almost impossible. Many times, these women become wheel chair bound.
Coordinated movement is not only controlled by motor neurons. The requirement
for coordinated movement is proper function in the pyramidal, extrapyramidal and
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propriosensory neuron systems. The pyramidal neurons control the contraction of
muscles. The extrapyramidal system provides information to the motor neurons that
help control muscle tone, joint angle and posture. Lastly, the propriosensory neurons
provide feedback to the other systems about the place of the limb in space, the muscle
force, and joint angles. Whereas motor neurons have been studied in RTT,
extrapyramidal and propriosensory neurons have not.
It has been shown that the movement of limbs is deficient in RTT patients. These
girls also have problems chewing and swallowing (Motil et al. 2012) and the difficulty in
eating causes malnutrition. Therefore, the understanding of the complications caused
by MECP2 mutations in the motor system is important to developing therapies to help
RTT patients. Propriosensory neurons of the mesencephalic trigeminal V (Me5) neurons
are crucial for the coordinated movement required during mastication. Thus, we
investigated the dysfunction of these neurons in RTT and provide evidence that Me5
neurons in Mecp2-/Y mice have altered membrane currents which seem to lead to
hyperexcitability.
Mecp2–/Y mice as a model system
In order to study the ramifications of the various mutations in exons 3 and 4,
many mouse model systems have been created. Some have been created that have
specific mutations. The Mecp2tm1Vnar or Mecp2*a140v consists of a missense mutation that
results in abnormal cellular morphologies in brain regions but no behavioral phenotypes
in males. However, phenotypes in females are arbitrary because of random Xchromosome activation. A nonsense point mutation in Mecp2R168X mice results in a
truncated protein that seems to impair function tremendously. These animals present
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many of the behavioral phenotypes found in other strains that have been widely used.
Also, when exons 3 and 4 were knocked out of GABAergic neurons only in Viaat-Mecp2
mice, the behavioral phenotypes found in these mice were similar to other mouse
models (Chao et al. 2010). It is worth noting that not only do mice with limited MeCP2
expression, but the overexpression of MeCP2 has proven to be detrimental to animals
as well. The overexpression of MeCP2 in mice causes abnormal nervous system
phenotypes, cognitive behaviors and seizures (Na et al. 2012; Taylor and Doshi 2012) .
The model system chosen for this study is commonly referred to as the “bird
model” named after the lab that originally created the strain. The Mecp2tm1.1Bird strain
created with a deletion of exons 3 and 4 (Guy et al. 2001). The deletion of both exons in
this model recapitulates all of the classical symptoms of RTT. The purpose of our
studies was to study the general impact of the Mecp2 gene mutations in neurons.
Therefore, we used a common mouse model where exons 3 and 4 have been removed
from the gene.
Benefits and drawbacks of the system
Every animal used in science as a model system has its positives and negatives.
These mice have been created by removing exons 3 and 4. We know from human
studies that over 600 known mutations have been discovered in girls suffering from RTT
(Weng et al. 2011). Each mutation will have its own, varying effect on the system.
We use male animals to study a disease that affects females primarily. Human
males still suffer from the disease, but they usually die at a very young age. That is the
reason for us to think of it as a female disease. We study males because the abnormal
movement, coordination and poor breathing are most prevalent in these animals. The
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decrease in the severity of the female symptoms is presumably due to the random Xinactivation described above. Conducting experiments on female Mecp2-/Y mice may
lead to confounding results. For example, it is very difficult to know if the cell that one is
patch clamping expresses the normal Mecp2 gene or the knockout in female mice.
Behavioral studies in female mice have seemed to be less conclusive as well.
Therefore, male mice may not be a perfect model for the disease, but it is appropriate
for studies that are not sex-related.

3

SIGNIFICANCE

RTT is a devastating disease with a high prevalence among females (Kerr et al.
1997). Not only do mutations in the MECP2 gene cause autism-like features in RTT, it is
also the origin of the breathing irregularities and motor dysfunction that underlie longterm disability and sudden death. Therefore, developing strategies to limit the impact of
MECP2 mutations on respiratory and movement centers in the CNS is necessary.
A cure for RTT has not been found. Many of the treatments are symptomspecific. NE and GABA reuptake blockers improve breathing in mouse models (Abdala
et al. 2010; Roux et al. 2007; Zanella et al. 2008). Each of these drugs only improves a
certain symptom, suggesting that multiple systems are affected. Indeed, recent studies
suggest serotonergic agonists seem helpful for breathing in humans with RTT (Andaku
et al. 2005; Gokben et al. 2012). Another important neurotransmitter system in the
brainstem is the cholinergic system. Increasing cholinergic signaling improves
movement problems (Nag and Berger-Sweeney 2007; Schaevitz et al. 2012). The
cholinergic system interacts with the NE and GABA systems regulating arousal state
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and other autonomic functions that are known to be defective in RTT. Therefore,
information on how the cholinergic system is affected by the Mecp2 disruption and how
it interacts with NE and GABA systems is highly significant, and should impact the
finding of novel therapeutic modalities for RTT.
The involvement of multiple neurotransmitter systems in RTT raises a new
question as to how these neurotransmitter systems are regulated so that each is
coordinated in the network and functions precisely in neuronal activity. The elaborate
control of neurotransmitter release or homeostatic regulation may allow central neurons
to respond to the deficiency in neurotransmitters and their receptors by upregulating
another neurotransmitter system or other members within the defective neurotransmitter
system. Such cell mechanisms are known as compensatory neuroadaptation that is
widely seen in experimental gene knockout as well as naturally occurring genetic
variations. Therefore, it is possible that the compensatory neuroadaptation takes place
in receptors and ion channels caused by Mecp2 disruption. We believe that
demonstration of the compensatory neuroadaptation in Mecp2–null mice is significant,
as this cellular mechanism may encourage further studies of the endogenously
upregulated proteins that can be targeted by therapeutic agents. The information may
also motivate people with RTT and their caretakers to actively boost or amplify the
existing endogenous mechanisms in the body by changing their lifestyle and using more
appropriate medication.
It is likely that the body can adapt to the MECP2 defects to avoid a complete
collapse of the system (death). The adaptations are not perfect since these women still
struggle with normal tasks. If we can intervene with therapeutics and reinforce what the
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body is doing already, it may reduce many of the complications associated with RTT.
Therefore, the identification of mechanisms that are in place in neurons to maintain
normal activity in Mecp2-null mice appears to be a significant first step towards finding
the cure for the disease.
4

METHODS

Animals
All experimental procedures in the animal were conducted in accordance with the
National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals
and were approved by the Georgia State University Institutional Animal Care and Use
Committee. Female heterozygous Mecp2tm1. 1Bird mice with the genotype Mecp2+/− were
purchased from the Jackson Laboratory (Bar Harbor, ME). Mecp2+/− females were
crossed with WT C57BL/6 males to produce the Mecp2−/Y male mice. The Jackson
Laboratory PCR protocol was used to confirm the Mecp2−/Y phenotype. The F1generation of 3 week-old, Mecp2−/Y males were used and their age-matched littermates
served as WT controls because overt symptoms do not show until 3 weeks.
Brain Slice Preparation
Brain slices were prepared as described previously (Cui et al. 2011; Zhang et al.
2010a). In brief, mice were decapitated after deep anesthesia with inhalation of
saturated isoflurane. The brain stem was obtained rapidly and placed in an ice-cold,
sucrose-rich artificial cerebrospinal fluid (sucrose aCSF) containing (in mM) 200
sucrose, 3 KCl, 2 CaCl2, 2 MgCl2, 26 NaHCO3, 1.25 NaH2PO4 and 10 D-glucose. The
solution was bubbled with 95% O2 and 5% CO2 (pH 7. 40). , Transverse pontine
sections (250-300 µM) containing the LC area were obtained using a vibratome
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sectioning system. The slices were transferred to normal aCSF in which the sucrose
was substituted with 124 mM NaCl, allowed to recover at 33°C for 1 h, and then kept in
room temperature before being used for recording. One of the slices was transferred to
a recording chamber that was perfused with oxygenated aCSF at a rate of 2 ml/min and
maintained at 34°C.
Identification of LC neurons
The LC neurons were identified by 1) their location between the pons and midbrain
below the lateral end of the 4th ventricle, 2) their morphological characteristics, as seen
under the CCD camera, and 3) their electrophysiological properties. Only neurons with
stable resting membrane potentials (Vm) more negative than -40 mV and action potentials
with amplitudes of >75 mV were used in the studies.
Identification of Me5 neurons
The Me5 neurons were identified by 1) their location between the pons and
midbrain below the lateral end of the 4th ventricle and lateral to the locus coeruleus area
2) their morphological characteristics, as seen under the CCD camera, and 3) their
electrophysiological properties. Only neurons with stable resting Vm more negative than
-50 mV and action potentials with amplitudes of ≥60 mV were used in the studies.
Electrophysiology in LC neurons
Whole-cell voltage clamp and current clamp studies were performed on cells
visualized using a near-infrared charge-coupled device (CCD) camera. Patch pipettes
were pulled with a Sutter pipette puller (Model P-97, Novato, CA) with a resistance of 4–
6 MΩ. The internal (pipette) solution for current clamp and whole cell nAChR current
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voltage clamp recordings contained (in mM) 130 K gluconate, 10 KCl, 10 HEPES, 2 MgATP, 0. 3 Na-GTP and 0. 4 EGTA (pH 7.30). The aCSF solution was applied to the
bath, containing (in mM) 124 NaCl, 3 KCl, 1. 3 NaH2PO4, 2 MgCl2, 10 D-glucose, 26
NaHCO3, 2 CaCl2 (pH 7.40 bubbled with 95% O2 and 5% CO2).The slices were
perfused with the external solution continuously with superfusion of 95% O2 and 5%
CO2 at 34°C. Whole-cell voltage clamp experiments were performed at a holding
potential of –70mV. For whole-cell nAChR current experiments, the synaptic currents
were blocked with the N-methyl-D-aspartate (NMDA) receptor antagonist, DL-2-Amino5-phosphonopentanoic acid (DL-APV, 10µM), the α-amino-3-hydroxy-5-methyl-4isoxazolepropionic acid (AMPA) receptor antagonist 6-cyano-7-nitroquinoxaline-2, 3dione (CNQX, 5 µM), the glycine receptor antagonist strychnine (1 µM), the GABAA
receptor antagonist, bicuculline (20µM) and the voltage-gated sodium channel blocker,
tetrodotoxin (TTX, 0.5 µM). When acetylcholine (ACh) was applied, the muscarinic
receptor antagonist, atropine (10µM) was used. The local perfusion pipette had a
resistance of 0.5-1 MΩ and just prior to either 100µM ACh or 100 µM nicotine in 1s and
44nl with the Nanoject II (Drummond Scientific, Broomall, PA), the perfusion pipette was
moved to within 20 to 30µm of the cell. Studies were conducted with food coloring to
make sure the pipettes did not leak the drug and to make sure the drug diffused quickly
in the bath. Immediately after drug application the perfusion pipette was removed from
the bath. A minimum of 45 min was allowed between each drug treatment to eliminate
any desensitization and no slice was exposed to the drug more than four times. After
the current was elicited by the drug, the cell contents were harvested into the patch
pipette with negative pressure and dropped into an Eppendorf tube containing 10XRT
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buffer, RNase-free water and RNase out (4.5:4.5:1), and then quickly placed in liquid
nitrogen until further processing. The cell capacitance was measured at the beginning of
the recording and any recordings where the series resistance changed during the
course of the experiment were rejected from further analysis. The internal pipette
solution for spontaneous GABAA receptor-mediated inhibitory postsynaptic currents
(sIPSCs) recordings contained (in mM): 50KCl, 2 MgCl2, 85 CsCl, 2 Mg-ATP, 1 NaGTP, 10 HEPES (pH 7.30). The external solution consisted of (in mM): 130 NaCl, 3. 5
KCl, 1. 25 NaH2PO4, 1. 5 MgSO4, 10 D-glucose, 24 NaHCO3, 2 CaCl2 (pH 7.40 with
95% O2 and 5% CO2). The sIPSCs were pharmacologically isolated by using 5 µM
CNQX, 10 µM DL-APV, and 1μM strychnine. The internal pipette solution for
glutamatergic spontaneous excitatory post-synaptic currents (sEPSCs) contained (in
mM): 135 Cs-methanesulfonate, 10 KCl, 1 MgCl2, 10 HEPES, 4 MgATP, 0.3 NaGTP
and 0.2 NaEGTA. The sEPSCs were isolated using 20μM bicuculline and 1μM
strychnine. Recorded signals were amplified with an Axopatch 200B amplifier
(Molecular Devices, Union City, CA), digitized at 10 kHz, filtered at 2 kHz, and collected
with the Clampex 9.2 data acquisition software (Molecular Devices).
Electrophysiology in Me5 neurons
All experiments were performed on brains slices. Cells from at least 3 animals
were used for data analysis. Patch pipettes were fabricated from borosilicate glass with
a resistance of 4-6MΩ. For current clamp and IH experiments, pipettes were filled with
(in mM): K-gluconate 130, KCl 10, Mg-ATP 2, Na-GTP 0.3, HEPES 10, EGTA 0.4 with
pH 7.35, and osmolarity 285 mmol/kg. NaCl (5mM) was included in the pipette solution
when recording Na+ currents. The bath solution for all recordings was regular aCSF.
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The post-inhibitory rebound (PIR) was elicited by giving a series of hyperpolarizing
current injections to the neuron. After the termination of the current injection, the cell
responded with a rebound that was more depolarizing than the resting membrane
potential. With step hyperpolarizations, the rebound became larger and larger until it
reached threshold and fired an action potential. The PIR was defined as the difference
between the peak depolarization (taken from the trace immediately before the action
potential was elicited) and the resting membrane potential. Using the same recording as
from the PIR, the sag was defined as the difference between the peak voltage during
the current injection and the steady-state voltage. The sag activation time constant was
determined using a single exponential Boltzmann equation. The IH was elicited by using
a step protocol from -140mV to +80mV. The half activation was determined by fitting the
data from the tail current to a curve created by using a single exponential Boltzmann
equation. The IH activation time constant was calculated using a single exponential
Boltzmann equation. The 4-Ethylphenylamino-1,2-dimethyl-6-methylaminopyrimidinium
chloride (ZD7288, Tocris Bioscience) and cesium chloride (Sigma Aldrich) were used to
block IH. The Na+ concentration was reduced from 140mM to 56mM when recording the
Na+ currents to reduce space clamp issues. For the Na+ current experiments, the cell
was held at -80mV. The Na+ currents were elicited using a step protocol from -70mV to
100mV. A second step protocol was performed that had a preceding step to +20mV that
lasted for 3.5ms to inactivate some K+ currents. We digitally subtracted the 2nd trace
from the 1st trace to minimize the K+ currents in the analysis, To measure the
inactivation of the Na+ currents we performed a step protocol from -120 to +30mV that
at the end had a depolarizing step held at +30mV for +80ms. The inactivation curve was
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fit to data from this protocol using a Boltzmann equation. The threshold was determined
using the maximum second derivative method (Sekerli et al. 2004). The Axopatch 200B
(Molecular Devices) were used for current clamp and voltage-clamp experiments. Data
were acquired using pCLAMP 9.0 sampled at 20kHz and filtered at 2kHz. Data were
analyzed using Clampfit and AXUM.
Reverse Transcription
Reverse transcription was performed on tissue obtained from brain slice
micropunches from either the LC or the Me5 area. The first strand cDNA synthesis was
performed using the high capacity cDNA reverse transcription kit (Life Technologies,
Grand Island, NY) per the manufacturer’s instructions. The reverse transcription product
was kept at -20°C until either single-cell PCR or qPCR was performed.
Single-cell PCR
PCR primers for the target genes were designed with the computer software program
primer express (Applied Biosystems). PCR product lengths were ~200bp so as to not
confuse them with primer dimers. 3µl of reverse transcription product was loaded into
an Eppendorf tube with PCR solution containing 10µl of 5X green GoTaq flexi buffer,
2µl MgCl2, 1µl of 10mM dNTP mix, 1µl of 10mM forward and reverse primers, 0.25µl of
GoTaq polymerase and diluted to 50µl with nuclease –free water. The thermal cycling
program was set to the initial denaturation for 5min at 95˚C for 1 cycle. The
denaturation, annealing, extension cycles were done at 95˚C for 45s, 58˚C for 45s and
72˚C for 1min, respectively for 35 cycles. A final extension cycle was done at 72˚C for
10min. 3µl of the PCR reaction placed into a 2nd PCR tube with the same solution as
before. The same cycling protocol was performed as before. 20µl from the 2nd PCR
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reaction was run on a 2% agarose gel containing ethidium bromide. Gels were imaged
using Alpha Innotech Imaging System (Alpha Innotech Corp., Santa Clara, CA). Images
were taken normally and a second with a high background. Presence of receptor
subunits in the LC cell was defined by having a band at the correct size regardless of
strength. Cells that had lanes with smearing or possible degradation were eliminated
from the experiment. Cells were tested for the glial fibrillary acidic protein (GFAP)
transcript for possible glia contamination. Any cells with positive results for GFAP were
eliminated from decay time analysis.
Quantitative PCR
qPCR primers for the target genes were designed with the computer software program
primer express (Applied Biosystems). qPCR product lengths were ~200bp so as to not
confuse them with primer dimers. For the qPCR, we used the SYBR select master mix
(Applied Biosystems). 2µl of reverse transcription product was added to the master mix
with 100nM of each primer. The directions for the PCR protocol were followed per the
manufacturer’s instructions. The qPCR was performed using the 7500 Real-Time PCR
System (Applied Biosystems).
Data Analysis
The electrophysiological data were analyzed with Clampfit 10.3 software
(Molecular Devices) and Mini Analysis Program 6.0.7 software (Synaptosoft Inc. New
Jersey, USA). Decay time constants were determined using a single exponential equation
in Clampfit. Data are presented as means ± SE. Statistical analysis of other parameters
were performed using the ANOVA and/or the two-tailed Student’s t-test. Difference was
considered significant when P ≤ 0.05.
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Abstract
Rett syndrome (RTT) is an autism-spectrum disorder resulting from mutations to
the X-linked gene, methyl-CpG binding protein 2 (MeCP2), which causes abnormalities
in many systems. It is possible that the body may develop certain compensatory
mechanisms to alleviate the abnormalities. The norepinephrine (NE) system originating
mainly in the locus coeruleus (LC) is defective in RTT and Mecp2-null mice. LC neurons
are subject to modulation by GABA, glutamate and acetylcholine (ACh), providing an
ideal system to test the compensatory hypothesis. Here we show evidence for potential
compensatory modulation of LC neurons by post- and presynaptic ACh inputs. We
found that the post-synaptic currents of nicotinic acetylcholine receptors (nAChR) were
smaller in amplitude and longer in decay time in the Mecp2-null mice than in the WT.
Single cell PCR analysis showed a decrease in the expression of α3, α4, α7 and β3
subunits and an increase in the α5 and α6 subunits in the mutant mice. The α5 subunit
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was present in many of the LC neurons with slow decay nAChR currents. The nicotinic
modulation of spontaneous GABAA–ergic IPSCs in LC neurons was enhanced in
Mecp2-null mice. In contrast, the nAChR manipulation of glutamatergic input to LC
neurons was unaffected in both groups of mice. Our current clamp studies showed that
the modulation of LC neurons by ACh input was reduced moderately in Mecp2-null mice
despite the major decrease in nAChR currents suggesting possible compensatory
processes may take place, thus reducing the defects to a lesser extent in LC neurons.
Introduction
Rett syndrome (RTT) is an autism-spectrum disorder caused by mutations to the
X-linked gene, methyl-CpG binding protein 2 (MeCP2)(Weng et al. 2011). The MeCP2
protein regulates transcription by binding to methylated DNA(Guy et al. 2011). Knockout
of this gene in mouse models leads to neurodevelopmental abnormalities such as
improper dendritic formation (Belichenko et al. 2009; Chapleau et al. 2009; Nguyen et
al. 2012), impaired synaptic transmission (Belichenko et al. 2009; Chao et al. 2007;
Shepherd and Katz 2011) and defective neurotransmitter-synthesizing enzyme
expression (Chao et al. 2010; Zhang et al. 2010b), all of which resemble symptoms of
RTT and may underlie the dysfunctional signaling between neurons.
People with RTT have defects in autonomic functions and brainstem
neuromodulatory systems. Norepinephrine (NE) is a major neuromodulator in the
central nervous system (CNS), that acts on breathing(Viemari et al. 2004; Viemari et al.
2011; Viemari and Ramirez 2006), cognition(Arnsten et al. 1988; Franowicz and
Arnsten 1999; Murchison et al. 2011; Veyrac et al. 2007), motor movement, pain(Baba
et al. 2000a; Baba et al. 2000b; Brightwell and Taylor 2009; Yoshizumi et al. 2012) and
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paradoxical sleep(Carter et al. 2010; Dugger et al. 2012; Pal and Mallick 2007;
Takahashi et al. 2010). The NE concentration is low in RTT patients and mouse models
of RTT (Panayotis et al. 2011; Santos et al. 2010; Zoghbi et al. 1989; Zoghbi et al.
1985). Application of desipramine, a NE-reuptake blocker, ameliorates the breathing
problems (Zanella et al. 2008; Zhang et al. 2011), further suggesting that the NE-ergic
system plays a role in the Mecp2-null phenotype. NE-synthesizing neurons are found
mainly in the locus coeruleus (LC) and project throughout the CNS. The NE deficiency
appears to result from inadequate expression of tyrosine hydroxylase (TH) and
dopamine-β-hydroxylase (DBH) in LC neurons of Mecp2−/Y mice (Zhang et al. 2010b).
Other problems that may contribute to low NE include smaller cell size, defects in
intrinsic membrane properties, and a decrease in CO2 chemosensitivity (Taneja et al.
2009; Zhang et al. 2011). Recent studies have shown that defects in presynaptic
modulation may affect normal LC neuronal activity as well. The GABA input to the LC is
decreased with reduced IPSC frequency and amplitude (Jin et al. 2013a). Also, as
opposed to 1-2 week old Mecp2−/Y mice, the allopregnanolone modulation of GABAA
receptors in 3 week old Mecp2−/Y mice is reduced, which is consistent with the onset
time of RTT-like symptoms in these mice (Jin et al. 2013b). Other studies indicate that
glutamic acid decarboxylase (GAD), the enzyme responsible for GABA production, is
down-regulated leading to less quantal release of GABA (Chao et al. 2010). Also,
blocking of the GABA transporter results in higher synaptic GABA levels and RTT
breathing symptoms are alleviated(Abdala et al. 2010). Lastly, when the Mecp2 gene is
knocked out of the GABA-ergic neurons only, RTT-like symptoms are apparent (Chao et
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al. 2010). Therefore, defects in NE-ergic and GABA-ergic signaling systems contribute
to the development of RTT symptoms.
A common link between the NE-ergic and GABA-ergic systems is the cholinergic
system. Through nicotinic acetylcholine receptors (nAChR), TH and GAD expressions
levels are regulated by the cholinergic system. The GAD expression levels are
increased by the activation of α4β2 receptors causing phosphorylation of MeCP2 and
release from DNA in cortical GABA-ergic neurons (Maloku et al. 2011). Less is known
about the mechanism, but the TH expression levels are increased by activation of
nAChRs in the LC (Osterhout et al. 2005) and the activation of α7 receptors in
heterologous expression systems up-regulates TH and dopamine-β-hydroxylase (DBH)
expression (Gueorguiev et al. 2000). The loss of cholinergic neurons (Wenk and HaussWegrzyniak 1999) and a decline in activity of choline acetyltransferase, an enzyme for
acetylcholine (ACh) biosynthesis (Wenk and Mobley 1996), impairs cholinergic
signaling. The dysregulation of the cholinergic system is believed to underlie the downregulation of the enzymes for GABA and NE biosynthesis.
These three systems are intimately linked in transitions between sleep states.
During rapid eye movement (REM) sleep, cholinergic neuron activity is increased (for a
full review (Pal and Mallick 2007)). In brief, acetylcholine silences LC neurons through
GABA-ergic input during REM sleep. LC neurons eventually escape this GABAmediated suppression and in turn cease cholinergic neuron firing during non-REM
sleep. Children with RTT have sleep abnormalities (Carotenuto et al. 2013) which have
been implicated in affecting cognition and memory (McCoy and Strecker 2011).
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Therefore, determining the modulation of LC neurons by ACh and GABA inputs in the
Mecp2−/Y mice may provide a basis for treatment in children with RTT.
Previous studies (Lena et al. 1999; Mitchell 1993; Vincler and Eisenach 2003)
and our own preliminary experiments indicated that the major cholinergic modulation of
presynaptic GABAergic and LC neurons occurs through nAChRs. The nAChRs are
pentameric cation-selective ligand-gated channels, which are found throughout the CNS
(Hogg et al. 2003; Romanelli et al. 2007). The nAChRs are abundant in LC neurons,
and activation of these receptors leads to an increase in neurotransmitter release in
several brain regions as well as the spinal cord (Hogg et al. 2003; Lena et al. 1999).
The subunit composition of nAChRs in the CNS is highly diversified with major
receptors consisting of homomeric α7, heteromeric α4β2, α6β4 and α9α10, although
other combinations have the potential to form functional channels.
There is a wealth of information on how the cholinergic, NE-ergic and GABAergic systems work to affect various behaviors. However, it is not known how the
signaling between these systems is compromised by neurodevelopmental diseases
when all three are affected. Lately, disease models have been emphasized for study of
RTT in an attempt to find possible pharmacological therapeutic approaches. However, it
is unclear how the widespread defects caused by the Mecp2 disruption affect multiple
modulatory systems. We hypothesize that the presynaptic and postsynaptic cholinergic
modulation of LC activity is compromised. Using patch clamp electrophysiology we
studied presynaptic and postsynaptic cholinergic modulation of LC neurons in WT and
Mecp2−/Y mice. This and single cell PCR allowed us to determine how changes in
nAChR expression altered nicotinic current kinetics in Mecp2−/Y mice. Our results
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suggest that the nicotinic receptor expression in LC and GABAergic neurons is altered
to maintain the cholinergic modulation of LC neurons in Mecp2−/Y mice.
Results
The whole-cell nAChR currents were altered in Mecp2−/Y mice
LC neurons were studied in brain slices obtained from WT and Mecp2−/Y mice.
We verified that the neuron was from the LC both visually and electrophysiologically as
we did previously (Zhang et al. 2010a). nAChR currents were recorded from the LC
neurons after the synaptic input was blocked with AP-5 (10μM), DNQX (5μM),
bicuculline (20μM), strychnine (1μM), TTX (1μM) and the muscarinic receptor
antagonist atropine (10μM). With the membrane potential held at -70mV in the voltage
clamp mode, a local application of 100μM acetylcholine (ACh, 44nl, in 1s) to the LC
area evoked large inward currents. The currents in the WT animal rose quickly, reached
the peak and decayed rapidly (Fig. 5.1A). However, a long lasting current was observed
in Mecp2−/Y cells (Fig. 5.1B). In comparison, the current amplitude was much larger in
WT neurons than in Mecp2−/Y cells (-109.7 ± 12.2pA, n= 31 and -46.8 ± 12.7 pA, n=11,
respectively; P<0.001, Mann-Whitney test; Fig. 5.1C), while the decay time was longer
in Mecp2−/Y neurons. The time constant obtained by fitting the decay time of the nAChR
currents with a single exponential equation was 2.4 ± 0.0.3 s (n=31) for the WT neurons
and 6.1 ± 2.3 s (n=10) for the Mecp2−/Y (P<0.01; Mann-Whitney test; Fig. 1E). The
longer decay time in Mecp2−/Y neurons was not due to the cell size, as LC neurons are
smaller in Mecp2−/Y mice than in the WT(Zhang et al. 2010a). With the cell size taken
into consideration, we compared the current density between the WT and Mecp2−/Y
mice, which was -7.2 ± 1.0 pA/pF (n=31) and -4.4 ± 1.4 pA/pF (n=11), respectively
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(P<0.05; Mann Whitney test; Fig. 5.1D). When we measured the area under the curve,
we found that there was no difference between the WT and Mecp2−/Y mice (-202.0 ±
32.4nA•ms WT vs. -170.3 ± 101.8nA•ms; n=31 and n=11, respectively; student’s t-test;
P>0.05; Fig. 5.1F). These results suggest that the Mecp2 knockout leads to nAChR
currents that are smaller in amplitude but last longer as shown in the decay time.
Previous studies indicated that atropine, a muscarinic receptor antagonist, may
interfere with nAChR activation (Zwart and Vijverberg 1997). Therefore, we verified the
ACh results by applying nicotine, a specific nAChR agonist, without any atropine to the
LC neuron during patch clamp recordings. A local application of 100μM nicotine (44nl, in
1s) resulted in larger currents in WT than in Mecp2−/Y mice (-122.7 ± 18.7 pA, n=10 in
WT vs. -41.1 ± 3.1 pA, n=12 in Mecp2−/Y; P<0.001; Mann-Whitney test; Fig. 5.2A-C).
Nicotine elicited similar whole cell current characteristics as ACh. The nicotine current
density differed significantly between WT and Mecp2−/Y (-7.7 ± 1.1 pA/pF WT vs. -2.8 ±
0.2 pA/pF Mecp2−/Y; P<0.001; Mann-Whitney test; Fig. 5.2D), and the decay time
constant was longer in Mecp2−/Y mice than in WT mice (2.7 ± 1.1s, n=10 in WT vs. 8.1 ±
0.7s, n=12 in Mecp2−/Y; P<0.001; Mann-Whitney test; Fig. 5.2E). The area was not
different either (-150.9 ± 34.6nA•ms vs. -107.09 ± 34.7nA•ms; n=10 and n=17,
respectively; student’s t-test; P>0.05; Fig. 5.2F).
The increase in decay time was attributable to alterations in nAChR subunit
expression
The changes in the amplitude and kinetics of nAChR currents may be due to the
alterations of the receptor species. Therefore, we analyzed the expression of nAChR
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subunits (α2-7, α9, α10 and β2-4) in each LC neuron with distinct nAChR currents using
the single-cell PCR assay. WT neurons expressed various combinations of α3, α4, α5,
α6, α7, α9, β2 and β3 transcripts although they were not expressed in every neuron
tested. Figure 3A shows the expression of α3, α4, α6, α7, α9 and β2, β3 in one LC
neuron, whereas another cell expressed α3, α7, α9, and β3 (Fig. 5.3B). Of the 19 WT
cells tested, the α7 and α9 transcripts were expressed in 14 and 18 cells, respectively
(Fig. 5.3D). The α5 and α6 subunits were expressed in 3 and 1 cells, respectively. The
α3 transcript was found in 9 cells, and the α4 subunit was found in 6 cells. The β3
subunit was seen in 16 neurons and the β2 subunit was only expressed in 2 cells and
the β4 subunit was not expressed in any cell tested (Table 2).
LC neurons from Mecp2−/Y mice expressed only α3, α5, α6, α9 and β3 subunits.
The α4 and α7, seen in most WT neurons, were not found in any of the 18 cells tested.
Although the β3 subunit was found in Mecp2−/Y neurons (Fig. 5.3C), there was a major
reduction in its expression which was seen in 8 of 18 cells in Mecp2−/Y mice instead of
16 of 19 in the WT. The only transcript that did not alter expression (in 17 out of 18
cells) was the α9 subunit. The α5 and α6 subunits were increased in the Mecp2−/Y mice
with the α5 subunit expression increased from 3 WT cells to 8 Mecp2−/Y cells and the α6
subunit increased from 1 WT cell to 3 Mecp2−/Y cells.
In order to determine whether the increase in decay time in Mecp2−/Y neurons is
attributable to alterations in the composition of nAChRs, we analyzed the decay times
and subunit expression. Owing to the sampling sizes, we combined the data with the
ACh and nicotine application. The WT decay time was shorter than the Mecp2−/Y mice
(3.3 ± 0.7s WT vs. 6.7 ± 1.2s Mecp2−/Y; n=19 WT and n=18 Mecp2−/Y; P<0.05; Mann-
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Whitney; Fig. 5.4A). Based on the single-cell PCR data and the fact that others have
noticed the interchangeability of these subunits (Dash et al. 2011; Gotti et al. 2005),
suggesting they may serve similar functions, the α5 and β3 subunits were likely
candidates for the decay time changes. We compared decay times of cells that
expressed either the α5 or β3 subunits, but not both. To do this, we omitted 4 cells from
the group that contained α9 only and 2 cells that expressed both α5 and β3. When the
α5 subunit was expressed, the decay time was 10.7 ± 2.5s (n = 6; Fig. 5.4B). When the
β3 subunit was present in WT and Mecp2−/Y mice without α5, the time constants were
similar (2.8 ± 0.5s WT vs. 4.23 ± 1.1s Mecp2−/Y; n=14 WT and n=6 Mecp2−/Y; student’s
t-test; P>0.3). When all 3 groups were compared to each other using a one-way
ANOVA, significant differences were found between the Mecp2−/Y group expressing the
α5 subunit and both β3- expressing groups (P<0.01). It is important to note that we also
compared the current amplitudes in the Mecp2−/Y mice for when α5 and β3 were present
or not, and found that there was no significant difference (data not shown).
The Mecp2−/Y mice had populations of cells that only contained combinations of
either α9β3 or α9α5. By removing one cell that expressed the α9, α3 and β3 and
another cell that expressed the α5, α6 and α9, we were able to take advantage of the
expression patterns in these neurons to determine whether α5 and β3 play a role in
decay time kinetics. We compared the decay time constants of these populations and
found that the α9β3-expressing neurons had a shorter decay time constant than the
α9α5-containing neurons (3.9 ± 1.2s α9β3 vs. 12.2 ± 2.5s α9α5; P<0.05; n=5 and n=5,
respectively; Fig. 5.4C).
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We also compared the contributions of the other subunits that were
downregulated in the Mecp2−/Y mice. The α3, α4 and α7 were downregulated in the
Mecp2 knockout, which may contribute to the decrease in current amplitude and the
increase in the decay time. Since these subunits were largely not present in the
Mecp2−/Y mice, we compared the current amplitudes and decay times when the subunit
was present or not in WT mice only. The presence of the α3 and α4 subunits did not
have any significant effect on the amplitude or decay time of the current (data not
shown). However, alteration in the nAChR current amplitude was seen depending on
the presence of the α7 subunit (-134.6 ± 19.0pA α7 vs. -67.9 ± 9.9pA no α7; n=14 and
n=5, respectively; student’s t-test; P<0.01; Fig. 5.5A). The decay was longer when α7
was not present (2.8 ± 0.6s α7 vs. 5.7 ± 1.6s no α7; n=14 and n=5, respectively;
student’s t-test; P<0.05; Fig. 5.5B). By teasing apart the data to determine the
contribution of the receptor subunits to the current amplitude and decay time, our data
suggest that the lack of α7 contributes mostly to the decrease in the current amplitude in
Mecp2−/Y mice and has some effect on the longer decay time, while the β3 subunit
contributes to the shorter decay time constant and the α5 confers a longer decay time
constant to the nAChR current. Therefore, the change of the subunit expression in the
Mecp2−/Y mice appears to cause alterations in the nAChR currents. The increase in the
proportion of cells with the α5 in Mecp2−/Y mice compared to WT and the decrease in
the β3 subunit proportion allows for the decay time to be increased in the knockout
mice.
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GABA-ergic input but not glutamatergic input was augmented by nicotinic
presynaptic modulation in Mecp2−/Y mice
The nAChRs modulate GABA and glutamate release in several brain areas. We
chose to study sPSCs of GABAA and glutamate receptors, as they are the prominent
synaptic currents in the CNS and are known to be dysregulated in RTT. To understand
the presynaptic modulation of LC neurons by acetylcholine in Mecp2−/Y mice, we
performed whole-cell patch clamp in the LC neurons and bath-applied the nAChR
agonist DMPP (10µM). The GABAA sIPSC frequency was augmented by the DMPP
application in LC neurons of WT and Mecp2−/Y mice, which was more obvious in the
Mecp2−/Y mice by 189.0 ± 10.1% (n=8) than in the WT by 147.1 ± 7.0% (n=8) (P<0.01,
Mann-Whitney test; Fig. 5.6A and B). The sIPSC amplitude was augmented in WT and
Mecp2−/Y mice, to a lesser degree though (110.5 ± 7.6% WT vs. 105.4 ± 6.7% Mecp2−/Y;
Mann-Whitney; P>0.05; n=8 for both; Fig. 5.6A and C). These led to a shift of the interevent interval cumulative probability to the higher frequency, which was greater in the
Mecp2−/Y mice without evident shift in the amplitude cumulative probability (Fig. 5.6E &
F). Consistently, the application of the nAChR antagonist mecamylamine (30μM)
caused a reduction in GABAA–mediated sIPSC frequency in WT mice to 78.2 ± 4.8%
(n=11, Fig. 5.7A & C). There was little change in the amplitude (96.4 ± 3.5%; n=11in
WT; Fig. 5.7D). The effect of mecamylamine on nicotinic modulation of GABA-ergic
sIPSC frequency was lowered to 62.6 ± 4.5% (n=11) in Mecp2−/Y neurons (Fig. 5.7B &
C), and the amplitude was unchanged 102.3 ± 4.0% (n=17; Fig. 5.7D). The shift to the
lower frequency of inter-event interval cumulative probability was larger in the Mecp2−/Y
mice than in WT (Fig. 5.7E). There was no shift in the amplitude cumulative probability
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(Fig. 5.7F). The inhibition of sIPSC frequency by mecamylamine was significantly
greater in Mecp2−/Y mice than that in the WT (P<0.01; Mann-Whitney), whereas the
amplitude difference was not (P>0.05; Mann-Whitney).
A decrease in MeCP2 expression levels dysregulates the excitatory synaptic
strength by reducing the number of glutamatergic synapses and by interrupting synaptic
scaling mechanisms (Blackman et al. 2012; Lozada et al. 2012a). Also, α7 and β2
subunits are instrumental in synapse and spine formation (Lozada et al. 2012a; b).
Because of this we tested whether the glutamatergic input to the LC is altered in
Mecp2−/Y mice and whether the cholinergic modulation was dysfunctional as well. We
recorded sEPSCs while applying DMPP (10μM). The baseline frequency was not
different between WT and Mecp2−/Y (2.1 ± 0.5 Hz WT vs. 2.2 ± 0.6 Hz Mecp2−/Y; n=11
and n=5, respectively). We found that there was an increase in frequency and amplitude
after the DMPP application. This increase in frequency was seen in both groups of mice
and showed no significant difference, though slightly smaller in the Mecp2−/Y mice
(159.1 ± 12.8% WT vs. 145.0± 6.9% Mecp2−/Y, n= 11 and n=5, respectively; P>0.05).
Cholinergic modulation of LC neuronal activity was sustained in Mecp2−/Y
mice despite a large decrease in nAChR currents
In order to determine the consequences of the cholinergic modulatory
dysfunction on the LC neuron firing activity we performed current clamp in WT and
Mecp2−/Y mice. Bath-application of DMPP (10μM) increased the activity of LC neurons
in WT mice from 4.5 ± 0.4 Hz to 6.7 ± 0.6 Hz (n=11; P<0.001; student’s t-test. Fig. 5.8A
and C), a 48% increase (Fig. 5.8E). The Input resistance was decreased from 424.8 ±
34.1 MΩ to 336.0 ± 27.5 MΩ (n=11; P<0.001; student’s t-test; Fig. 8A), a 20% decrease
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(Fig. 5.8F), and the neurons were depolarized from -45.9 ± 1.1 mV to -44.6 ± 1.2 mV
(n=11; P>0.05; student’s t-test; Fig. 5.8G). We also performed the same experiment by
applying 50μM ACh (data not shown). There was very little difference between the ACh
and DMPP treatments (~6%). This suggests very little muscarinic receptor influence on
LC neuron postsynaptic properties. The DMPP treatment raised the LC neuronal firing
activity in Mecp2−/Y mice from 3.8 ± 0.5 Hz to 5.2 ± 0.7 Hz (n=11; P<0.001; student’s ttest; 5.8B and D), a 37% increase (Fig. 5.8E), and reduced the input resistance from
547.5 ± 67.7 MΩ to 454.4 ± 54.8 MΩ (n=11; P<0.001; student’s t-test; 5.8B), a 17%
decrease (Fig. 5.8F). The neuron was depolarized from -48.5 ± 2.2 mV to -46.3 ± 2.5
mV (n=11; P>0.05; student’s t-test; Fig 5.8G). When the changes in firing frequency,
input resistance and membrane potential were compared using the Mann-Whitney test,
there were no differences between the WT and Mecp2−/Y mice (Fig 5.8E-G).
Discussion
In the present study we found that the postsynaptic nAChR currents in LC
neurons of Mecp2−/Y mice is altered. This alteration in the current amplitude and decay
time constant is likely due to changes in expression of specific nAChR subunits, namely
the α5, β3 and α7. We also found that the nAChR modulation of GABA input to the LC
is enhanced in Mecp2−/Y mice whereas the cholinergic modulation of glutamatergic input
is unchanged.
Changes in nAChR subunit expression may be responsible for altered
current
Previous studies have shown that nAChR mediated current characteristics can
be attributed to the expression of the subunits by a particular cell. Many have used
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pharmacological agents and molecular techniques to block different subunits and thus
alter the amplitude and decay time constant of the current (Albuquerque et al. 1997;
Alkondon and Albuquerque 1993; Alkondon et al. 1999; Rothlin et al. 2000) . This line of
research leads one to some generalizations of the subunit contribution to the nAChR
current. The α7 subunit is usually associated with a large transient peak whereas the α3
and α4 subunits are associated with smaller amplitude currents with a longer decay time
(Flood et al. 1997; Liu and Berg 1999; Zhao et al. 2003). In single channel recordings,
the α5 subunit increases the mean open time (Ciuraszkiewicz et al. 2013) and the
insertion of β3 can shorten the decay time (Boorman et al. 2003). WT LC neurons
display a variety of nAChR subunits that contribute to different kinetics of an elicited
current (Lena et al. 1999). Consistent with these findings we found that these current
changes are attributable to changes in subunit expression. The loss of α7 expression in
the Mecp2−/Y group seems to underlie the decrease in the current amplitude. When we
compared the current amplitudes for when α7 was present or not in WT mice, the
absence of the α7 subunit caused a reduction in amplitude that was similar to the
Mecp2−/Y amplitude. When we compared the decay times to the presence of certain
receptor subunits, we found that the α5 and β3 seemed to make a large impact on it.
The α5 seemed to confer a long decay time whereas the β3 subunit caused a short
decay time. These data seem to suggest that since the α3, α4 and α7 are severely
down-regulated in the Mecp2−/Y mice, there may be direct regulation of their expression
by MeCP2 as opposed to the other subunits. The β3 is down-regulated by half which
implies that it may be indirectly regulated by MeCP2 or not at all. Consequently, it may
be altered by the overall changes in other receptors. Since MeCP2 is a transcription
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repressor, the loss of function may result in a larger expression of the α5 subunit.
However, it is still unclear which upstream proteins affect expression of the β3 or α5
subunits.
Adaptations in LC neurons of Mecp2−/Y mice
Maintaining homeostasis is essential for living and adapting to new
environments, stimulations or perturbations. Much work has been done to study
homeostatic mechanisms in the nervous systems of normal animals, while much less is
known about how the body adapts to disease. The understanding of disease
progression requires knowledge of how the system (body) acts to prevent the onset of
symptoms or diminish them. However, compensation mechanisms for neuronal
dysfunction in disease models have received relatively little attention. It is
understandable when functional assay results do not show any difference between WT
and the knockout, one would assume there is no change in the system. In the case
here, we found that the nAChR whole-cell currents and receptor expression changed in
the Mecp2−/Y mice without any cholinergic modulatory deficits to the LC neurons. Our
data support the possibility that compensatory mechanisms may be in place to alleviate
deficits in neurotransmission found in RTT.
Whether compensatory mechanisms exist in RTT is still elusive. We have found
that the Mecp2 knockout leads to a reduction in the nAChR current amplitude while the
decay time of the currents is much longer. The decrease in amplitude is likely mediated
by deficient expression of α7 subunits. However, it seems that the LC neurons are
capable of limiting the effect of the reduction in amplitude by up-regulating α5 in the
Mecp2−/Y mice. These changes lead to prolonged nAChR currents that appear to
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maintain postsynaptic modulation of LC neurons. Concerning a difference in the
cholinergic facilitation, the firing activity of Mecp2−/Y neurons was only 11% smaller (Fig.
8) than that of the WT in contrast to ~64% deficiency in the postsynaptic nAChR current
amplitude (Fig. 2). Thus, these results are consistent with certain endogenous
compensatory processes that may exist, allowing LC neurons to significantly diminish
the consequences of Mecp2 knockout defects. The question arises, can a current
amplitude reduction of ~64% result in more than an 11% decrease in LC activity? We
feel that it is highly likely. Based on the literature, nAChR activation has several effects
on neurons that are consistent with this line of thought. Activation of nAChRs increases
can induce cell firing from silence. When the α7 receptor is blocked, the action potential
induction is blocked as well (Ji and Dani 2000). The firing frequency in area prostrema
neurons are increased more with 30μM nicotine than with 10μM. nAChR activation also
increases the excitability of these neurons thus causing an increased response to a
depolarizing current (Funahashi et al. 2004). Further, Neurons can be depolarized and
the input resistance decreases in a dose-dependent manner (Zhong et al. 2013). Lastly,
we measured the area of the nAChR current by multiplying the current amplitude by the
total time. When we compared the WT and Mecp2−/Y mice areas, they were not different
(Fig. 1F & 2F). If the current amplitude was reduced without a change in the decay time
constant, then the area would be much smaller. Since the total cation charge crossing
the membrane would be much less, the changes in membrane potential, input
resistance and firing frequency of LC neurons would be less. Here we do not see that.
Therefore, it does seem that the changes in expression of subunits does have some
positive effect on the cholinergic modulation of LC neurons. The decrease in α7 and β3
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may indirectly contribute to the increase in the decay time as well. When we compared
decay times based on the presence of α7 in WT mice, we found that when no α7 was
present, the decay time was longer. Since no Mecp2−/Y mice expressed the α7 subunit,
it is reasonable to assume the loss of α7 had some impact on the decay time constant.
The impact of the loss of β3 may be substantial as well. In the 2 Mecp2−/Y cells that
contained both α5 and β3, the cells had a short decay time. With this data and the fact
that most WT cells with short decay times expressed β3, we can assume the β3 plays a
large role in shaping the nAChR current decay. We studied mice at the age where the
neurodevelopmental symptoms of RTT occur. At this age, if the cell is adapting to the
loss of the α7 subunit by reducing β3 expression and increasing α5, then there may be
a larger variability in the subunit expression here than one would see at older ages.
Therefore, other studies should be done to thoroughly examine how the receptor
subunit expression changes in LC neurons at different ages in WT and Mecp2−/Y mice.
The nAChR modulation of GABA-ergic inputs to the LC is enhanced in the
Mecp2−/Y mice. This enhancement is likely caused by an increased sensitivity of the
nAChR to DMPP. It is not clear if the increased sensitivity is due to an up-regulation of
the same receptor subtype or an alteration in the composition of the nAChR. The α4β2,
α7 and α6-containing nAChRs increase release of GABA through different mechanisms
in different brain regions (Aracri et al. 2010; Nakamura and Jang 2010; Yang et al.
2011; Zappettini et al. 2011). One of these receptor types could mediate the increase in
nAChR modulation of GABA release. Our data suggests that alterations in nAChR
composition seem to occur in GABA-ergic neurons. However, an alternative hypothesis
is that the α4β2 nAChR, a known regulator of GAD expression, is up-regulated to
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compensate for the low GAD expression in GABA neurons. In this case, the increase in
GABA release may be an unintended consequence to the up-regulation of the α4β2. In
this second scenario, the disruption of normal MeCP2 function would have to be
occurring through a different mechanism than in the LC or at different ages than we
were testing.
The adaptations seen here at the neuronal level help to maintain proper
modulation of LC neurons. One may make some predictions if these adaptations did not
exist or were not compensatory. Due to the reduction in ACh release and subunit
expression in animal models for RTT, If there were no compensatory mechanisms in
place, the cholinergic modulation of LC neurons and GABA neurons would be much
less. Here, we do not see this. We see that the LC modulation is relatively maintained
and cholinergic modulation of GABAergic neurons is enhanced. If the adaptations were
independent or linked with no compensatory benefit, then one would predict these
values would be similar to a neuron with a nAChR current with a small amplitude and
small decay. Thus, the cholinergic modulation of LC neurons would be greatly
diminished.
In conclusion, our studies demonstrate several potential endogenous
mechanisms underlying the avoidance of a total collapse of the LC system due to the
Mecp2 knockout. The up-regulation of the α5 subunit seems to increase the decay time
of the whole cell nAChR current in Mecp2−/Y mice thereby reducing the impact of the
major decrease in current amplitude by the down-regulation of the α7 subunit. This
compensation seems to maintain some level of cholinergic modulation to the LC
neurons. We have also shown that the nAChR modulation of GABA input to the LC is
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enhanced in Mecp2−/Y mice, which appears to compensate for the defects in GABAergic input to LC neurons found previously. We believe that these findings are
encouraging, as the information may help the design of a new generation of therapies
by targeting possible endogenous compensatory mechanisms.
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Figures

Figure 5.1 The nAChR currents were altered in LC neurons from Mecp2−/Y mice.
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A: A 100µM ACh pulse (1s, 44nl) elicited a large transient current with a short decay
time in LC neurons from WT mice B: A 100μM ACh pulse (1s, 44nl) elicited currents
with a small amplitude and a long decay time in LC neurons Mecp2−/Y mice. C: The
current amplitude was smaller in Mecp2−/Y mice than WT mice. D: The current density
was smaller in Mecp2−/Y mice than WT mice. E: The decay time was longer in Mecp2−/Y
mice than in WT mice. The decay time was determined using a single exponential
equation. F. The area under the current curve measured by multiplying the amplitude by
the time was similar between both groups. Bar graphs are means ± SE; n = 31 WT and
n = 11 Mecp2−/Y (Mann-Whitney; P < 0.05 *, P < 0.001 ***)

60`

Figure 5.2 Nicotine elicited a similar current to ACh in WT and Mecp2−/Y mice.
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A: 100µM nicotine pulse (1s, 44nl) elicited a large transient current with a short decay
time in LC neurons from WT mice. B: A 100µM nicotine pulse (1s, 44nl) elicited a small
amplitude current with a long decay time in LC neurons Mecp2−/Y mice. C: The current
amplitude was smaller in Mecp2−/Y mice than WT mice. D: The current density was
smaller in Mecp2−/Y mice than WT mice. E: The decay time is longer in Mecp2−/Y mice
than in WT mice. The decay time was determined using a single exponential equation.
F. The area under the current curve measured by multiplying the amplitude by the time
was not significantly different between both groups. n = 10 WT and n = 12 Mecp2−/Y;
Mann-Whitney; P < 0.01 **, P < 0.001 ***.
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Figure 5.3 Receptor subunit expression in identified LC neurons.
Cytoplasm was extracted from LC neurons after local perfusion with either ACh or
nicotine. A: nAChR expression from one WT LC neuron B: A second LC neuron
showing a different expression pattern than in (A). C: nAChR expression in LC
neuron from Mecp2−/Y mice D: Number of cells that contained each nAChR subunit.
(n =19 cells WT and n =18 cells Mecp2−/Y). Black bar is equal to 200 base-pairs.

63`

Figure 5.4 LC neurons from Mecp2−/Y mice expressing the α5 subunit had longer
decay times than β3-expressing neurons.
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White bars are data from WT mice and black bars are data from Mecp2−/Y mice. A: The
nAChR current in LC neurons from Mecp2−/Y mice displayed longer decay times than
WT mice; n = 19 and n = 18 (Mann-Whitney). B: α5-expressing LC neurons from
Mecp2−/Y mice had a long decay time. β3- expressing LC neurons from WT and
Mecp2−/Y mice had short decay times (n = 6 Mecp2−/Y with α5; n = 14 WT with β3, n = 6
Mecp2−/Y with β3 (one–way Anova) C: LC neurons from Mecp2−/Y mice that expressed
α9α5 receptors had longer decay times than neurons that expressed α9β3 receptors (n
= 5 α9α5 and n = 5 α9β3; Mann-Whitney). Bar graphs are means ± SE; (P < 0.05 *, P <
0.01 **)

Figure 5.5 Presence of the α7 subunit affects the current amplitude and decay
time constant in LC neurons from WT mice.
A. Cells expressing the α7 subunit have a larger whole cell nAChR current amplitude in
WT mice than cells not expressing α7. B. Cells expressing the α7 subunit have a
shorter whole cell nAChR current decay time constant in WT mice than cells not
expressing α7. n= 14 α7 and n=5 No α7; student’s t-test; P<0.05 *, P<0.01 **.
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Figure 5.6 Cholinergic modulation of GABA-ergic input to LC neurons with nAChR
agonist in Mecp2−/Y mice is enhanced compared to WT mice.
A: LC neurons of WT mice were patch clamped and GABA-ergic sIPSCs during
the 5 min baseline and during a 5min, 10μM DMPP treatment were recorded. B: LC
neurons of Mecp2−/Y mice were patch clamp and recordings during the 5 min baseline
recording of GABA-ergic sIPSCs and during a 5min, 10μM DMPP treatment were taken.
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C: The frequency increase seen in the WT mice was enhanced in Mecp2−/Y mice. D:
The amplitude did not show a significant difference during DMPP treatment. There was
no difference between WT and Mecp2−/Y mice as well. E: Cumulative fraction of Interevent interval before and during 10μM DMPP treatment. Dashed lines are from baseline
and the solid lines are from the 10μM DMPP treatment. Gray lines are from WT LC
neurons and black lines are from Mecp2−/Y LC neurons. Shift to the left during DMPP
treatment in Mecp2−/Y mice was greater than in WT mice. F: Cumulative fraction of
amplitude before and during 10μM DMPP treatment. Dashed lines are from baseline
and the solid lines are from the 10μM DMPP treatment. Gray lines are from WT LC
neurons and black lines are from Mecp2−/Y LC neurons. Mecp2−/Y mice shifted due to
the DMPP treatment. (n = 8 WT and n = 8 Mecp2−/Y; Mann-Whitney; P < 0.01 **)
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Figure 5.7 Cholinergic modulation of GABA inputs to the LC neurons with a
nAChR antagonist is enhanced in Mecp2−/Y mice.

A: LC neurons of WT mice were patch clamped and GABA-ergic sIPSCs during the 5
min baseline and during a 5min, 30μM mecamylamine treatment were recorded. B: LC
neurons of Mecp2−/Y mice were patch clamp and recordings during the 5 min baseline
recording of GABA-ergic sIPSCs and during a 5min exposure to 30μM mecamylamine
were taken. C: The frequency decrease seen in the WT mice was enhanced in Mecp2−/Y
mice. D: The amplitude showed no significant difference during DMPP treatment. There
was no difference between WT and Mecp2−/Y mice. E: Cumulative fraction of Inter-event
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interval before and during 30μM mecamylamine treatment. Dashed lines are from
baseline and the solid lines are from the 30μM mecamylamine treatment. Gray lines are
from recordings of WT LC neurons and black lines are from Mecp2−/Y LC neurons. The
shift to the right during mecamylamine treatment in Mecp2−/Y mice was greater than in
WT mice. F: Cumulative fraction of amplitude before and during 30μM mecamylamine
treatment. Dashed lines are from baseline and the solid lines indicate the 30μM
mecamylamine treatment. Gray lines are from WT LC neurons and black lines are from
Mecp2−/Y LC neurons. There is no shift between the baseline and drug treatment for
both groups. Bar graphs are means ± SE; n = 9 WT and n = 17 Mecp2−/Y (MannWhitney; P < 0.01 **).
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Figure 5.8 There is a small but insignificant difference in nicotinic modulation
of LC neurons from WT and Mecp2−/Y mice.
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A: Patch clamp recordings of LC neuronal firing activity in WT mice before, during and
after 10μM DMPP treatment. Each inset is for the hyperpolarizing current indicating the
input resistance. B: Patch clamp recordings of LC neuronal firing activity in Mecp2−/Y
mice before, during and after 10μM DMPP treatment. Each inset is for the
hyperpolarizing current indicating the input resistance. C: Frequency was analyzed from
the recording made in (A). This shows that 10μM DMPP increases the frequency in WT
mice. D: Frequency was analyzed from the recording in (B), and 10μM DMPP increased
frequency in Mecp2−/Y mice. E: There was no significant difference in the increase in
firing frequency between WT and Mecp2−/Y mice. F: The difference in input resistance
modulation by 10μM DMPP between WT and Mecp2−/Y mice was insignificant. G: 10μM
DMPP depolarized the LC neuron in WT and Mecp2−/Y mice. There was no significant
difference between groups. Bar graphs are means ± SE; n = 11 WT and n = 13
Mecp2−/Y (Mann-Whitney; ns = Not Significant).
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Table 4.1 Nicotinic Receptor PCR Primers
Target Gene

Primer Sequence

Accession No.

α2
α2

Fw : CTTTGGAGGCTACAATCGCTG
Rv : TTCCATTCCTGCTTTAGCCAG

NM_144803

α3
α3

Fw : GACCTCCCAAACAGCATTGC
Rv : TCTGACAACCGAGGCACACA

NM_145129

α4
α4

Fw : ACATGGAACAGGACCGCTG
Rv : ACAAAAGGCCGGCTGAGTG

NM_015730

α5
α5

Fw : GCGCTCGATTGCATTCG
Rv : CCCTAGCGTCCCAATGATTG

NM_176844

α6
α6

Fw : CCCCTGCCTCTTCATTTCC
Rv : ACCACAATGGACAGCGTG

NM_021369

α7
α7

Fw : GCTGCAAAGAGCCATACCC
Rv : GATCTCAGCCACAAGCAGC

NM_007390

α9
α9

Fw : CCAGCCATCACCAAAAGCTC
Rv : ATGCCCTGAACCTCCCATTC

NM_001081104

α10
α10

Fw : ACTGGCTCACAAGCTGTTTCG
Rv : CACCTCCAGGGTCACATTTAGAG

NM_001081424

β2
β2

Fw : CATTGCGGACCATATGCG
Rv : TCACGGGATGAGTAGCTGC

NM_009602

β3
β3

Fw : CCAAGGCCATTGTGAAATCC
Rv : TCCGGTCAACGTTTCATTG

NM_009602

β4
β4

Fw : TGGCTTGCACTGATCGCTC
Rv : AAATGAAAGACGGCCAGGG

NM_148944

GAPDH
GAPDH

Fw : CCAGCCTCGTCCCGTAGA
Rv : TGCCGTGAGTGGAGTCATACTG

NM_008084
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Abstract
RTT victims have motor defects seen in Mecp2-null mice as well. Motor neurons
have been studied for possible roles in the movement abnormalities. However,
propriosensory neurons, whose excitability can affect the feedback to motor neurons
necessary for coordinated movement, have not. To address this issue, we studied the
mesencephalic trigeminal (Me5) neurons. In whole-cell current clamp, the sag potential
and PIR were reduced in Mecp2-null mice by ~35% and ~20%, respectively, suggesting
a reduction in the hyperpolarization-activated current (IH), a regulator of membrane
excitability. In voltage-clamp, the IH density was deficient by ~33%, and the steady-state
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half-activation had a depolarizing shift of ~10mV in the Mecp2-null mice. Quantitative
PCR analysis indicated that HCN2 was decreased by ~30%, and the HCN1 was
upregulated by ~35% with no change in HCN4 in Mecp2−/Y mice compared to WT.
Despite the major deficiency in IH, the Me5 neurons were more excitable in Mecp2-null
mice due to a decrease in the firing threshold. Consistently, the steady-state halfactivation of voltage-gated Na+ currents (INa) displayed a hyperpolarizing shift in the
Mecp2-null mice with no change in the INa density. This seems to be due to NaV1.1,
SCN1B and SCN4B overexpression and NaV1.2 and SCN3B under-expression. These
data suggest that instead of disruption, the Mecp2 knockout leads to reorganization of
membrane ion channels, thereby reducing the impact of their defects on the membrane
excitability of Me5 neurons.
Introduction
Rett syndrome (RTT) is an autism-spectrum disorder caused by mutations in the
Methyl-CpG- binding protein 2 (MECP2) gene. People with RTT have motor defects that
are also found in Mecp2−/Y mice. It is known that voluntary motor function relies on the
pyramidal, extrapyramidal and propriosensory systems. Although defects in the motor
systems have been described in humans (Chahrour and Zoghbi 2007; Hagberg et al.
1983; Rett 1966) and in mice (Blue et al. 1999; Jin et al. 2013c; Kao et al. 2013), there
is still a lack of information of the propriosensory system with respect to changes in
neuronal intrinsic membrane properties and cellular excitability. The propriosensory
neurons act as a part of servo feedback control by providing motor neurons with
essential information regarding muscle tension, joint angle, movement speed and
spatial position of body parts (Cattaneo and Pavesi 2014; Winter et al. 2005).
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Consequently, defects in proprioception play an important role in motor dysfunctions
and diseases (Dietz and Duysens 2000; Patel et al. 2014).
The mesencephalic trigeminal nucleus (Me5) contains a group of neurons
responsible for the proprioception of jaw and facial muscles (Hidaka et al. 1999; Kolta et
al. 1990; Zakir et al. 2010). Defects in chewing and swallowing are seen in people with
RTT (Isaacs et al. 2003; Motil et al. 2012) suggesting Me5 neurons may be affected.
With clear anatomical location and morphological characteristics, these Me5 neurons
are ideal for studying the effects of the Mecp2 knockout on propriosensory neurons.
Therefore, we performed these studies while paying special attention to ionic
mechanisms underlying membrane excitability because changes in cellular excitability
would affect proprioception and, ultimately, motor function.
Neuronal hyperexcitability has deleterious effects on various behaviors including
movement (Vucic and Kiernan 2006; Zanette et al. 2002), anxiety (Davis et al. 1994;
Zhou et al. 2010) and pain (Ke et al. 2012; Laedermann et al. 2013). Much work has
been done on Me5 neurons concerning the ionic currents that underlie their excitability
and activity (Del Negro and Chandler 1997; Enomoto et al. 2007; Enomoto et al. 2006;
Hsiao et al. 2009; Khakh and Henderson 1998; Tanaka et al. 2003; Wu et al. 2005; Wu
et al. 2001). In addition, blocking the various membrane currents in these neurons alters
firing activity and neuronal excitability. Therefore, if the Mecp2 disruption affects ion
channel expression, it will likely alter the excitability and proprioception function of the
Me5 neurons.
In this study, we found that Me5 neurons in the Mecp2−/Y mice had major defects
in the hyperpolarization-activated currents (IH) and voltage-gated Na+ currents (INa),
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likely to result from abnormalities in the transcript expression levels of the subunits
mediating the currents. These defects occur in a way that seems to reduce the impact
of their changes on the membrane excitability. The seemingly normal homeostatic
response to the defect in one current by changing another seems to prevent a drastic
change in neuronal excitability and, presumably, the resultant devastating
consequences of motor dysfunction.
Results
Several intrinsic membrane properties regulate cellular excitability, including the
resting membrane potential, post-inhibitory rebound (PIR), firing threshold and repetitive
firing, all of which were studied in Me5 neurons from both the WT and Mecp2−/Y mice.
The average resting membrane potential was -56.3 ± 1.1mV WT (n= 33 neurons) vs. 56.3 ± 0.8mV Mecp2−/Y mice (n=30 neurons), which were not significantly different from
each other (p=0.96).
Post-inhibitory rebound and sag in WT mice
With a series of hyperpolarizing currents, WT neurons displayed a large PIR (Fig
1A1) and sag (Fig. 1A2). The sag is the difference between the trough and the steadystate potentials (Fig. A3), whereas the PIR is defined as the peak depolarization above
the resting membrane potential immediately before firing (Fig. 1A4). Measured at the
sub-threshold firing level, the PIR and the sag averaged 14.9 ± 0.6mV (n=33 neurons,
mean ± s.e.) and 63.8 ± 3.8mV (n=33 neurons), respectively (Fig. 1B). We compared
the sag to its activation time constant using a Spearman’s rank correlation and found
that the larger the sag, the faster the time constant (r=0.66, Fig. 1C). A similar
correlation was found between the PIR and sag (r=0.70, Fig. 1D). We calculated the
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input resistance by dividing the peak potential by the injected current. We found that the
resistance was 154.5 ± 12.4MΩ (n=33 neurons).
IH is known to be the major player in both the sag and PIR. Thus, we blocked the
IH with ZD7288 (10µM). The ZD7288 treatment caused the sag and PIR to be greatly
reduced (Fig. 1E1-E3). Such effects could mostly be washed out. The baseline PIR was
reduced from 11.2 ± 0.8mV to 3.5 ± 0.5mV (n=6 neurons; P<0.001, Student’s t-test; Fig.
1F) and the sag was reduced from 50.7 ± 7.8mV to 21.6 ± 5.0mV (n=6 neurons;
P=0.010, Student’s t-test; Fig. 1F). The resting membrane potential was hyperpolarized
by the ZD7288 treatment from -52.9 ± 1.9mV to -59.1 ± 1.4mV (n=6 neurons; P<0.05,
Student’s t-test).
Decreases of PIR and sag in Mecp2−/Y mice
In comparison to WT Me5 neurons, the sag (immediately before firing) was
reduced in the Mecp2−/Y mice (63.8 ± 3.8mV WT vs. 42.2 ± 3.3mV Mecp2−/Y, n=33 and
n=30 neurons, respectively; P<0.001, Student’s t-test; Fig. 2A and C). The PIR
(immediately before firing) was reduced as well (14.9 ± 0.6 mV WT vs. 10.8 ± 0.6mV
Mecp2−/Y, n=33 and n=30 neurons, respectively; P<0.001, Student’s t-test; Fig. 2B and
D). In order to determine the relationship between the sag amplitude and PIR amplitude,
we compared them in a conventional scatter plot (Fig. 2E). Me5 neurons from Mecp2−/Y
mice and WT mice overlapped to some degree. However, many of the WT Me5 neurons
displayed relationships with large PIR and sag amplitudes whereas the Mecp2-null
neurons displayed relationships with small PIR and sag amplitudes. These data indicate
that the relationship between the sag and PIR indeed holds true in the Mecp2−/Y mice,
just at smaller amplitudes compared to WT. The time constant for the sag was

77`

significantly different between these neurons as well (18.1 ± 2.1ms in WT vs 27.0 ±
3.3ms in Mecp2−/Y, n=33 and n=30 neurons, respectively; P<0.05, Student’s t-test; Fig.
2F). Lastly, we found that the input resistance was increased from 154.5 ± 12.4MΩ WT
(n=33 neurons) to 218.2 ± 26.7MΩ Mecp2−/Y (n=30 neurons) which was significantly
different (P<0.05, Student’s t-test).
Reduction in IH in Mecp2−/Y mice
Based on the current clamp data and the ZD7288 effects, it is likely that I H is
involved the sag and PIR. Thus, we measured IH in voltage clamp before and after
ZD7288 treatment (Fig. 3A and 3A2). When we took the difference between them, we
found that most of the inward currents elicited by our voltage protocol were the I H (Fig.
3A3). Then, we examined the steady-state activation of the IH by measuring the tail
currents (Fig. 3A1) resulting from the return to -70mV after step command voltages. For
the cell in Fig. 3A1, the maximum amplitude of IH was -743.5pA. The voltage for halfactivation (V½) determined by fitting the data with the Boltzmann equation was -83.0mV
with the slope Boltzmann constant, k, 15.0mV (Fig. 3B). In the I/V plot, the neuron in
Fig. 3A3 had a reversal potential ~-30mV (Fig 3C) indicating a combination of Na+ and
K+ for the currents, which is a characteristic of IH. We were able to confirm that it was IH
by blocking the currents with 1mM Cs+, a concentration known to block IH mostly rather
than K+ currents (-1,937 ± 178pA at baseline vs. -568 ± 97pA with Cs+, n=10 neurons,
P<0.001; Student’s t-test; Fig. 3D). Consistently, the specific IH blocker ZD7288
suppressed the currents (-960 ± 180pA at baseline vs. -221.6 ± 7.7pA with ZD7288, n=8
neurons, P<0.001; Student’s t-test; Fig. 3E).
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To analyze the difference of IH between the WT and Mecp2−/Y mice, we applied
the same voltage-clamp protocol to Mecp2-null neurons. The IH from Mecp2−/Y mice was
much smaller than that from the WT (Fig. 4A & B). The current density in Me5 neurons
from Mecp2−/Y mice was lower as well. When the cell was voltage-clamped at -130mV,
the current density was 16.0 ± 0.8 pA/pF in WT vs. 10.1 ± 1.7 pA/pF in Mecp2−/Y (n=26
WT neurons and n=13 Mecp2−/Y neurons; P<0.001, Student’s t-test; Fig. 4D). When the
steady-state activation was compared between WT and Mecp2−/Y mice, we found that
the V½ was shifted toward more depolarizing potentials (-82.6 ± 1.5mV vs. -72.5 ±
2.7mV in 10 WT and 9 Mecp2−/Y neurons, respectively; P<0.01; Student’s t-test; Fig. 4E
& F). Furthermore, the activation time constant was longer in the Mecp2−/Y mice than in
the WT (48.5 ± 3.2ms vs. 72.4 ± 8.9ms in 18 WT and in 17 Mecp2−/Y neurons,
respectively; P<0.05; Student’s t-test; Fig. 4C and G).
Impact on firing and repetitive firing activity
The reduction in IH and the PIR should affect firing activity in Me5 neurons of
Mecp2−/Y mice. Since these cells did not fire action potentials spontaneously, we studied
the firing activity by giving a series of depolarizing currents. We found that in 13 of 18
WT neurons, only single action potentials were elicited (Fig. 5A and C), whereas the
other 5 cells fired multiple action potentials during the depolarizing pulses. In contrast,
18 of 23 Mecp2-null neurons fired multiple action potentials in response to the same
depolarizing current protocol, whereas only 5 cells fired single action potentials (Fig. 5B
and C). The difference in their ratios was statistically significant (P<0.001, χ² test).
When we compared the frequency of action potentials during the depolarizing
current injection between these mice, the overall firing rate was significantly higher in
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Mecp2−/Y mice than in the WT (Fig. 5D). For example, when the Me5 neuron was
injected with 290pA, the Mecp2−/Y firing frequency was 166.3 ± 30.7Hz (n=10 neurons)
whereas the WT was 30.3 ± 14.1Hz (n=10 neurons; P<0.001, Student’s t-test; Fig. 5D).
There was little difference in spike frequency adaptation in Me5 neurons from WT and
Mecp2−/Y mice (data not shown). These results suggest that the cellular excitability is
increased in Mecp2–null neurons.
The increased cellular excitability in Mecp2-null neurons was quite surprising,
with the decrease in the IH we expected these neurons to be less excitable. Although
reduction in the IH was partially compensated by the shift in the V½ to more depolarizing
potentials, the average PIR remained small in Mecp2-null neurons (as mentioned
above). It is likely that mechanisms other than the IH may play a role. Thus, we analyzed
the firing threshold using the maximum second derivative method (Sekerli et al. 2004).
We found that the threshold was -34.7 ± 1.0mV in WT vs. 41.3± 1.1mV in the Mecp2−/Y
(n=26 and n=25 neurons, respectively; P<0.001 Student’s t-test; Fig. 5E and F). The
latency to first spike was not significantly different (2.83 ± 0.26ms WT vs. 2.78 ± 0.22ms
Mecp2−/Y, n=21 and n=23 neurons, respectively; P>0.05; Student’s t-test; Fig. 5G).
These results indicate that despite the decreases in IH and PIR, the firing threshold is
reduced in Mecp2-null neurons making the cells more excitable in response to
depolarization input.
Alteration of voltage-gated Na+ currents in Mecp2−/Y mice
It is possible that the decreased firing threshold is attributable to the voltagegated Na+ currents (INa). Thus, we analyzed INa in voltage clamp. To minimize the
space-clamp error, we reduced the extracellular Na+ to 56mM instead of 145mM in
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regular ACSF. The INa amplitude was about the same between the WT and Mecp2−/Y
mice (-6.8 ± 0.7nA WT vs. -6.8 ± 0.6nA Mecp2−/Y, n=8 neurons for both; Student’s t-test,
P>0.05, Fig. 6A & B). The current density was not significantly different either (-145.5 ±
15.4pA/pF in WT vs. -151.4 ± 15.4pA/pF in Mecp2−/Y, n=8 neurons for both; P>0.05,
Student’s t-test; Fig. 6C). When the steady-state activation and inactivation of INa were
compared between these neurons, we found that the activation curve was shifted to
more hyperpolarizing potentials in Mecp2−/Y mice (Fig. 6D). The V½ was -19.6 ± 2.6mV
(n=8 neurons) for the WT and -25.9 ± 3.1mV (n=8 neurons) for the Mecp2−/Y mice,
consistent with the decrease in firing threshold in the Mecp2-null neurons. In contrast,
the INa inactivation was not significantly different between WT and Mecp2−/Y mice, which
was fit with the same Boltzmann equation (Fig. 6D).
Evidence for altered expression of HCN and Na+ channels in Mecp2−/Y mice
The changes in IH may be related to alterations in the expression of the major
pore-forming subunits that mediate the IH. Thus, we performed qPCR analysis to
determine the hyperpolarization-activated and cyclic nucleotide-gated (HCN) transcript
levels in WT and Mecp2−/Y mice. Using the 2−ΔCT method in comparison to
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (Livak and Schmittgen 2001),
we found that in micropunches from WT mice the HCN2 transcripts were expressed the
most (n=9 experiments) compared to GAPDH, the HCN1 and HCN4 transcripts were
next (n=9 and n=8 experiments, respectively; Fig. 7A). The difference in the HCN2
expression was significantly different from HCN1 and HCN4 (one-way ANOVA, Fig. 7A).
No significant difference was found between HCN1 and HCN4. When the relative
quantity of HCN expression was compared to that of the WT using the 2−ΔΔCT method,
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we found that HCN2 in the Mecp2−/Y mice was reduced (P<0.001; Student’s t-test; n=9
experiments, Fig. 7B). In contrast, the HCN1 transcript expression was increased to
(P<0.001; Student’s t-test; n=9 experiments; Fig. 7B), and the HCN4 expression
remained unchanged (P>0.05; Student’s t-test; n=8 experiments, Fig. 7B).
Since functional Na+ channels consist of one α and two auxiliary β subunits
which can affect the current kinetics, we performed qPCR on the four CNS-expressing α
subunits (NaV1.1, 1.2, 1.3 and 1.6) and four β subunits (SCN(1-4)B). We compared the
expression levels of each subunit to GAPDH using the 2−ΔCT method. The NaV1.2 and
SCN1B were the most abundant subunits in the WT group (n=9 experiments for both;
Fig. 8A), followed by SCN2B (n=8 experiments), NaV1.6 (n=9 experiments), NaV1.1
(n=9 experiments), SCN3B (n=9 experiments) and SCN4B (n=9 experiments). The
NaV1.3 was expressed in a very low level (n=9 experiments).
When the relative expression of these Na+ channel subunits was compared
between the WT and Mecp2−/Y mouse, we found that the most abundant subunit,
NaV1.2 was decreased (n=9 experiments; P<0.001, Student’s t-test; Fig. 8B) and
another abundant subunit, SCN1B, was increased (n=9 experiments; P<0.05, Student’s
t-test; Fig. 8B). The lesser expressed subunits, NaV1.1 and SCN4B were increased
(n=9 experiments for both; P<0.001NaV1.1 and P<0.001SNC4B, Student’s t-test; Fig.
8B) and SCN3B was decreased (n=9 experiments; P<0.01, Student’s t-test; Fig. 8B).
NaV1.3, NaV1.6 and SCN2 expression levels were altered very little in the Mecp2−/Y
mice compared to WT (n=6 experiments; n=8 experiments; n=8 experiments,
respectively; Fig.8B).
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Discussion
In the present study, we provide first evidence for dysfunction in propriosensory
neurons of Mecp2−/Y mice. We find that the sag potential and the PIR are greatly
reduced in Me5 neurons from Mecp2−/Y mice, due to a decrease in IH. However, the
Mecp2-null Me5 neurons do not show a decrease in excitability, but are hyperexcitable
instead. Our results suggest that the hyperexcitability of the Me5 neurons results from a
reduction in the firing threshold, attributable to a hyperpolarizing shift in the INa V½ of
activation. The molecular basis for the changes in IH and INa properties seems to be
related to changes in the channel expression levels.
IH alterations in Mecp2−/Y mice
The IH is produced by HCN channels and plays a role in many different functions
such as PIR, setting of the resting membrane potential, regulation of membrane
excitability, pacemaking, integrating synaptic input and bursting of action potentials
(Chan et al. 2011; Li et al. 2012; Lupica et al. 2001; Nolan et al. 2007; Ying et al. 2011).
All four HCN transcripts have been reported in the rodent brain (Santoro et al. 2000). In
Me5 neurons of the Mecp2−/Y mice, the IH density is decreased by ~30%, consistent with
reductions in the sag and PIR. Its V½ of activation displays a depolarizing shift of
~10mV. We find that in WT mice the HCN2 is expressed the most, with HCN1 an order
of magnitude less and HCN4 two orders less. The HCN3 transcript is not detected in the
Me5 area. In the Mecp2−/Y mice, the HCN2 expression is reduced by ~30% and the
HCN1 was increased by ~35% with no change in HCN4. Therefore, the HCN2
deficiency in Mecp2-null neurons appears to underlie the decrease in the IH density.
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The alterations in the HCN transcript expression may explain the changes in the
IH properties as well. Concerning the activation V½ in WT animals, the V½ is ~ −70mV for
HCN1, ~ −100mV for HCN4, and −75mV to −95mV for HCN2 and HCN3, respectively
(Altomare et al. 2003; Baruscotti et al. 2005; Stieber et al. 2005; Wahl-Schott and Biel
2009). The Mecp2-null Me5 neurons show an increase in HCN1 expression and a
decrease in HCN2 expression. The expression level of HCN2 is 10-fold higher than
HCN1 in Me5 neurons of WT mice. Thus, a 30% reduction in the HCN2 expression
appears to be the main reason for the shift in the activation V ½ of IH.
A decrease in the IH density would result in a decrease in membrane excitability.
(Deng et al. 2014; Funahashi et al. 2003; Kim and Holt 2013). The unexpected increase
in the excitability in Mecp2-null neurons, despite the decrease in the IH density, may be
attributed to the depolarizing shift in the V½ of activation. Although the combination of
the reduction in HCN2 and increase in HCN1 may explain the decrease in the I H current
density and the activation V½ shift to a depolarizing potential, it cannot explain the
decrease in firing threshold. Therefore, we studied the voltage-gated Na+ currents.
INa alterations in Mecp2−/Y mice
Functional Na+ channels consist of one large α subunit (NaV 1.1 to 1.9) and two
smaller auxiliary β (β1-β4) subunits. The α subunits are responsible for voltagedependent gating properties, whereas the β subunits modify the gating, Na + channel
expression and cell adhesion (Patino et al. 2011). Our voltage clamp experiments
showed a hyperpolarizing shift of the V½ of activation by ~5mV in the Mecp2−/Y mice.
We have found alterations in the expression of NaV1.1, NaV1.2 and SCN1B, SCN3B
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and SCN4B indicating a cause for the hyperpolarizing shift in the V½ of activation and
firing threshold.
Previous studies indicate that the level of NaV1.2 is reduced in LC neurons from
Mecp2−/Y mice (Zhang et al. 2010a). We find similar results in Me5 neurons including
that the NaV1.2 is the most expressed α subunit in the WT mice. The SCN1B and
SCN4B expressions are increased in Mecp2−/Y mice compared to WT. These two
subunits modulate the V½ of activation in Na+ currents by causing a hyperpolarizing shift
(Aman et al. 2009; Barela et al. 2006). Currents involving the NaV1.2 show more
positive activation V½ values than currents composed of the other α subunits (OuYang
and Hemmings 2007; Rush et al. 2005; Xu et al. 2007), whereas the NaV1.1 mediated
currents tend to have more negative V½ values than other subunits. Taken together,
these data indicate that the hyperpolarizing shift in the V½ of activation is due to
alterations in the transcript expression of the NaV1.1, NaV1.2, SCN1B and SCN4B Na+
channel subunits. Based on other studies (Dai et al. 2002; Power et al. 2012), it is likely
that the shift in the V½ underlies the decreased threshold found in the Me5 neurons.
Homeostatic reorganization of HCN and voltage-gated Na+ channels in
Mecp2−/Y mice
Me5 neurons are propriosensory cells that monitor, and respond to, muscle
stretch through muscle spindles and Golgi tendon organs. Neuroanatomical studies
indicate that not only do Me5 neurons innervate trigeminal motor neurons, but also
premotor interneurons in the supratrigeminal nucleus, spinal trigeminal subnucleus and
parvocellular reticular formation (Luo et al. 2001). Many of these interneurons are
inhibitory which also play a role in coordinated movements (Turman and Chandler
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1994). Through these interneurons, motor neurons for mastication and facial expression
are regulated by Me5 neuronal activity, thereby affecting the coordinated and rhythmic
mastication as well as meaningful facial expression.
In Mecp2−/Y mice, the Me5 neurons show defects in both IH and INa, likely
because of the defective expression of several subunits of these channels. The defects
in these ion channels seem to counterbalance each other, as the IH defects tend to
reduce membrane excitability, and the INa defects tend to increase it, thereby reducing
any possible negative consequences. A straightforward explanation for this
phenomenon is that there may be a physiological homeostatic compensatory
mechanism in these neurons, although which current initiates the homeostatic
reorganization of the other is still unclear. Regardless of the cause vs. the compensator,
the impact of the homeostatic reorganization is very clear. Without the homeostatic
reorganization, the Me5 neurons would either be severely hypoexcitable or extremely
hyperexcitable, which would make the voluntary movement of jaw and certain facial
muscles very difficult or maybe even impossible. Despite the homeostatic
reorganization, the Me5 neurons are somewhat hyperexcitable due to the decrease in
firing threshold. However imperfect this may be, it seems to be more beneficial than if
the homeostatic reorganization of these ion channels did not occur at all.
Other possible contributors to the intrinsic hyperexcitability
There has been much work that shows neuronal excitability is regulated by K +
currents (Barros et al. 1994; Gryshchenko et al. 1999; Perez et al. 2006) and the
persistent Na+ currents (INaP) (Astman et al. 1998; Vervaeke et al. 2006). The inwardly
rectifying K+ currents (IKir) that are present in Me5 neurons (Del Negro and Chandler

86`

1997; Tanaka et al. 2003) are altered in LC neurons of Mecp2−/Y mice (Zhang et al.
2011). Although the IKir regulates cell excitability, we did not see any difference in Me5
neurons when we blocked IKir with Ba2+ (data not shown). There is an increased INaP in
cardiomyocytes from Mecp2−/Y mice (McCauley et al. 2011) but no studies have been
performed on neurons. INaP does play a role in regulating the excitability and bursting in
Me5 neurons (Enomoto et al. 2006; Wu et al. 2005) and the knockout of NaV1.6
decreases the INaP and excitability in Me5 neurons (Enomoto et al. 2007). Since we see
no change in NaV1.6 expression here, NaV1.6 is unlikely to affect the excitability in
Mecp2-null Me5 neurons. It is possible that the increase in the expression of the other
voltage-gated Na+ channels increases the INaP in Mecp2−/Y mice, but as of now, it
remains unclear.
In conclusion, we have found major defects in HCN channels with respect to their
electrophysiological properties and subunit expression in Mecp2–null Me5 neurons. The
~30% decrease in IH does not cause a decrease in membrane excitability. Instead, the
membrane excitability is slightly increased in the Mecp2–null neurons, likely to result
from the hyperpolarizing shift in the INa V½ of activation. This seemingly paradoxical
phenomenon can reduce the impact of the defects in these two major groups of ion
channels and allows Me5 neurons to maintain decent proprioception in mastication and
facial expression in the presence of the Mecp2 disruption. These findings may have an
impact on the understanding of propriosensory neurons regarding their function in motor
control and the development of motor impairment in people with RTT. Also, these
findings may provide insight into ion channel reorganization and its role in alleviating
symptoms caused by genetic defects in cellular functions.
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Figure 6.1 ZD7288 blocks the strong sag and PIR in Me5 trigeminal neurons.
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A: The Me5 neuron responded to the hyperpolarizing current with a strong PIR and sag,
A1 and A2. The sag was described as the difference between the peak voltage and the
steady-state voltage during the current injection, A3. The PIR was the difference
between the baseline voltage and the peak rebound voltage after the termination of the
current injection, A4. B: The PIR and sag in the Me5 neurons from WT mice. C:
Correlation between the sag time constant and sag voltage. D: The correlation between
the PIR and sag. E: The IH antagonist ZD7288 blocks the sag and PIR. E1: The
recordings after ZD7288 application to same neuron as in E. E2: Overlay of the
maximum sweep from traces in E and E1. E3: Overlay of the maximum sweep from E2
focusing on the PIR. F: The PIR and sag are less after the ZD7288 treatment. Bar
graphs are means ± SE; n=6 neurons (Student’s t-test; P < 0.01 **, P < 0.001 ***)
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Figure 6.2 . PIR and sag are less in Me5 trigeminal neurons from Mecp2−/Y mice.
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A: The sag from a Me5 neuron from WT mouse. A1: The PIR from a Me5 neuron from a
WT mouse. The sag was defined as the difference between the peak voltage induced
by the hyperpolarizing current injection and the steady-state voltage. The PIR was
defined as the difference between the resting membrane potential and the peak
depolarization. Only recordings without action potentials shown. B: The sag in a Me5
neuron from a Mecp2−/Y mouse. B1: The PIR in a Me5 neuron from a Mecp2−/Y mouse.
C: The sag is smaller in Mecp2−/Y mice than in WT. D: The PIR is smaller in Mecp2−/Y
mice than in WT. E: The WT population of cells (open circles) have larger PIR and sag
values than the Mecp2−/Y mice (filled circles). F: The sag time constant is longer in
Mecp2−/Y mice than in WT. Bar graphs are means ± SE; n = 33 WT neurons and n=30
Mecp2−/Y neurons (Student’s t-test; P < 0.05 *, P < 0.001 ***)
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Figure 6.3 The hyperpolarization-activated current in Me5 trigeminal propriosensory
neurons.
A: The hyperpolarization-activated current in Me5 neurons. The cell was held at -70mV
and a voltage step protocol was administered from -140mV to 0mV. A1: The tail current
after the cell returned to -70mV. The arrow indicates where the current values used for
the steady-state activation curve were taken. A2: ZD7288 blocks the hyperpolarizationactivated current in Me5 neurons. A3: The trace from A2 was subtracted from trace in A.
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B: The steady-state activation was determined from the tail current in A 1. C:
Current/voltage plot made from subtracted trace in A3. D: Cesium strongly reduced the
hyperpolarization-activated current E: ZD7288 reduced the hyperpolarization-activated
current. Bar graphs are means ± SE; n = 10 Cs+ neurons and n=8 ZD7288 neurons
(Student’s t-test; p < 0.001 ***)
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Figure 6.4 The hyperpolarization-activated current was altered in Me5 trigeminal
neurons from Mecp2−/Y mice.
A: Me5 neuron voltage-clamp recording from WT mouse. B: Me5 neuron voltage-clamp
recording from Mecp2−/Y mouse. C: Comparison between the activation of the current in
WT and Mecp2−/Y mice. D: The steady state activation curves of the hyperpolarizationactivated current in Mecp2−/Y (closed circle) mice compared to the WT (open circle). E:
The current density was smaller Mecp2−/Y mice than in WT (n = 26 WT and n=10
Mecp2−/Y). F: The half-activation was depolarized in Mecp2−/Y mice compared to WT (n
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= 10 WT neurons and n=9 Mecp2−/Y neurons). G: The activation time constant was
longer in Mecp2−/Y mice than in WT (n = 18 WT neurons and n=17 Mecp2−/Y neurons).
Bar graphs are means ± SE, (Student’s t-test; p < 0.05 *, p < 0.01 **)
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Figure 6.5 Excitability was increased in Me5 neurons of Mecp2−/Y mice.
A: A series of depolarizing currents elicited single action potentials in most WT cells. B:
A series of depolarizing currents elicited multiple action potentials in most Mecp2-null
neurons. The middle between A and B show typical action potentials during injected
currents. C: Pie charts depicting average of neurons that responded with single action
potentials or multiple action potentials in WT and Mecp2−/Y mice. D: The spontaneous
frequency of action potentials due to depolarizing injected current compared between
WT (open circles) and Mecp2−/Y (dark circles) mice; n=10 WT neurons and n=10
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Mecp2−/Y neurons. E: Action potential threshold comparison between WT and Mecp2−/Y
mice. The threshold (X) was determined using the maximum second derivative F: The
threshold was decreased in Mecp2−/Y mice compared to WT; n=28 WT neurons and
n=26 Mecp2−/Y neurons. G: The spike latency was unchanged between WT and
Mecp2−/Y mice; n=28 WT neurons and n=26 Mecp2−/Y neurons. Graphs are means ±
SE; (Student’s t-test; P < 0.01 **, P < 0.001 ***)

97`

A

C

−/Y

WT

pA / pF

WT

1 nA
1 ms

B

−/Y

20

g / gmax

D

−/Y

-50 mV
-90

Vm (mV)

Figure 6.6 The steady state half-activation of voltage-gated sodium current was
shifted in the hyperpolarized direction in Mecp2−/Y mice.
A: The voltage-gated sodium current recordings from WT and Mecp2−/Y mice when the
cell was held at -90mV and a step protocol from -80mV to +60mV. B: The voltage-gated
sodium current recordings from Mecp2−/Y mice. Note: only the recordings from steps 50mV to +20mV are shown. C: The current density was similar between WT and
Mecp2−/Y mice. D: The steady-state half-inactivation was different between the WT
(open circle) and Mecp2−/Y mice (closed circle) by ~15mV. The steady state halfactivation was shifted in the hyperpolarized direction in Mecp2−/Y mice compared to WT.
Bar graphs are means ± SE; n=8 WT neurons and n=8 Mecp2−/Y neurons (Student’s ttest, P > 0.05)
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Figure 6.7 Alterations in HCN subunit expression in Me5 neurons.
A: The relative quantity of the HCN subunits compared to GAPDH. B: The relative
quantity of the HCN subunits of Mecp2−/Y mice compared to WT. Bar graphs are means
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± SE; n=9 experiments HCN1 and HCN2, n=8 experiments HCN4, (one-way ANOVA
and Student’s t-test; p < 0.01 **, p < 0.001 ***)
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Figure 6.8 Alterations in NaV and SCN subunit expression in Me5 neurons.
A: The relative quantity of the NaV and SCN subunits compared to GAPDH. B: The
relative quantity of the NaV and SCN subunits of Mecp2−/Y mice compared to WT. Bar
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graphs are means ± SE; n=9 experiments NaV1.1, NaV1.2, NaV1.6, SCN1B, SCN3B,
SCN4B, n=8 experiments SCN2B, n=6 experiments NaV1.3 (one-way ANOVA and
Student’s t-test; p < 0.01 **, p < 0.001 ***)
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Table 5.1 Na+ Channel PCR Primers
Target Gene
Primer Sequence
GAPDH FW
CCAGCCTCGTCCCGTAGA

Accession No.
NM_008084

GAPDH RW

TGCCGTGAGTGGAGTCATACTG

NaV1.1 Fw

TCATCATCTTCGGGTCCTTC

NaV1.1 RV

GGTCGAGGGATAGGCTTTTG

NaV1.2 Fw

GCTAAAGTGGGTTGCATATG

NaV1.2 RV

CCTCAGTGCTCTTAATGTTC

NaV1.3 Fw

CGCTTGACGCTGTCTTCTG

NaV1.3 RV

GACTTCAGTGGGATAGGAGGG

NaV1.6 Fw

AGTCAGACCCCGAAGGCAG

NaV1.6 RV

TGTTGACCTGGCAGCACTTG

SCN1B Fw
SCN1B Rv

CGAGGCTGTGTATGGGATGAC
CCCTCAAAGCGCTCATCTTC

NM_011322.2

SCN2B Fw
SCN2B Rv

GGTCTGGTGGCGATTTAAACTG
AACGACTCAGCCCTATCTTTCC

NM_001014761.2

SCN3B Fw
SCN3B Rv

TGTAATGTGTCCAGGGAGTTTG
TTCGGCCTTAGAGACCTTTCTG

NM_001286614.1

SCN4B Fw
SCN4B Rv

AGCCTCGCTTTCTGATGGTGATC
TCCCTTCCCTGTCTTCAATCTC

NM_001013390.2

NM_018733.2

NM_001099298.2

NM_018732.3

U26707.1
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7

GENERAL DISCUSSION

Homeostatic compensation in animal models
Homeostasis occurs in cells, tissues, organs and organisms. For proper neuronal
function the balance among various membrane ion channels and synaptic currents must
be maintained. Recent studies indicate that membrane conductance varies from
neurons to neurons even though the neuronal output is quite robust and stereotypical
(Prinz et al. 2004). The stability of neuronal activity seems to be related to the
covariation of certain membrane conductance pairs (Zhao and Golowasch 2012). The
alteration of one conductance in the pair may not alter the neuronal firing activity. This is
because the other membrane conductance is also altered (Khorkova and Golowasch
2007; MacLean et al. 2003). These conductance alterations are related to the ion
channel expression level, turnover rate, phosphorylation, membrane trafficking, etc.
(Schulz et al. 2006; Tobin et al. 2009), which are consistent with the compensatory
neuroadaptation theory. It is likely that similar neuroadaptations that occur in WT
animals happen in diseased mouse models of RTT.
Gene knockout mouse models
There are many examples where the knockout of a gene from an organism
initiates compensatory mechanisms. Alterations in the gene expression levels in
response to the knockout of another gene indicate that cells have the ability to adapt to
the genetic variations. For example, when the α1 subunit gene of the GABAA receptor is
knocked out, other genes start acting in the functional deficiency caused by the gene
ablation (Ogris et al. 2006). Due to the α1 GABAA receptor subunit knockout, there is an
increase in expression of α6, α3 and α4 -containing channels. This is not necessarily
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caused by upregulation of the genes. Instead, the gene products are not degraded as
much and are incorporated into functional receptors. The global knockout of the β3
GABA receptor gene causes the downregulation of the α2 and α3 subunits (Ramadan
et al. 2003). These changes are not limited to the GABA system. When the NE
transporter is knocked out, there is an increase in α2 adrenoceptors, dopamine and
serotonin transporters (Gilsbach et al. 2006; Solich et al. 2011). Several lines of
knockout mice have been used to study the function of nAChRs because of their role in
nicotine addiction (Drago et al. 2003). In α7 nAChR knockout mice, the α2, α9, α10, β4,
muscarinic 1 and muscarinic 4 receptor subunits were upregulated in retinal neurons
(Smith et al. 2014). Further, the α3 and α4 nAChR subunits are upregulated in the
cortex and hippocampus of α7 nAChR knockout mice. These results suggest that
neurons have the ability to alter the expression of one gene to compensate for a
deficiency in the other.
Parkinson’s disease mouse models
The loss of dopamine signaling has been shown to be the major cause of
Parkinson’s disease. Specifically, dopaminergic neurons from the substantia nigra pars
compacta die due to dysfunction in the L-type Ca(v)1.3 Ca2+ channel (Chan et al. 2007).
Despite the death of these neurons, the advent of the symptoms do not occur until the
level of striatal dopamine is <5% of WT values (Golden et al. 2013). This cannot be
explained without consideration of neuroadaptations compensating for the diminishment
of dopamine signaling in the striatum. Indeed, neurons of the striatum are able to adapt
to the reduction of dopamine. The decrease in cholinergic and GABAergic neurons of
the striatum seems to occur to adjust to the decline in dopamine (Lloyd 1977). Further,
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when 90% of the substantia pars compacta neurons are destroyed, there is an
upregulation in TH expression and release of dopamine from the remaining neurons
(Zigmond et al. 1984). The dopamine transporter activity is decreased when substantia
nigra pars compacta neurons are lesioned. This seems to help maintain the dopamine
levels despite the reduced number of dopaminergic neurons (Sossi et al. 2009). These
examples offer reasons why the decrease in dopamine does not immediately result in
obvious Parkinson’s disease symptoms.
Rett Syndrome mouse models
There are many mouse models used to study the impact of mutations in the
Mecp2 gene. Depending on the question being asked, one model may be more
appropriate than another. For instance, some mutations have more severe symptoms
than others. For our purposes, we used the model where exons 3 and 4 were removed,
and the model recapitulates all RTT-like symptoms. Using this model we have found
evidence where neurons are adapting to changes in synaptic signaling and membrane
ionic currents. RTT is characterized by deficits in inhibitory systems. It seems that other
systems are able to act on minimizing the Mecp2-null effect. In the mice, GABA synaptic
transmission is defective, whereas the NE modulation of glycinergic input to hypoglossal
neurons is augmented (Jin et al. 2013c). The upregulation of the inhibitory glycinergic
synaptic currents seems to reduce the hyperexcitability of hypoglossal neurons. The
ACh modulation of GABA input to LC neurons is increased in Mecp2-/Y mice, which
seems to increase the GABAergic input to the LC. The alteration of presynaptic neuron
signaling is just one neuroadaptation occurring to maintain homeostasis. Other
compensatory neuroadaptations occur in postsynaptic neurons as well. The expression
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of nAChR receptor subunits in LC neurons is reorganized. The reduction in α3,α4, α7
and β3 seems to be offset by the increase in the α5 subunit. The nAChR current
properties are altered due to the changes in the expression of the subunits that mediate
it. The ability of the cholinergic neurons to modulate LC activity is maintained. This
compensatory neuroadaptation allows the signaling between cholinergic and NEergic
neurons to be preserved in spite of the problems caused by the knockout of the Mecp2
gene.
Not only do ligand-gated ion channels or ionotropic receptors seem to be
affected by the MeCP2 dysfunction, voltage-gated ion channels are altered as well. We
have shown that the expression of HCN and voltage-gated Na+ channels is altered in
Me5 propriosensory neurons. These alterations in the channels suggest that the MeCP2
deficiency is affecting the expression of one group of ion channel. The alterations in the
one group compensate for the changes in the other. It is difficult to say if HCN or
voltage-gated Na+ channel expression is affected by the Mecp2-null and which one
compensates. It does seem clear that without the compensatory mechanisms, the
neuron would be completely unable to function properly. For example, if the Mecp2
knockout decreases IH without any compensation by INa, it is likely that the neuron would
not be able to fire action potentials as easily. Therefore, the reduction in the threshold
becomes necessary for these neurons to communicate with other brain stem neurons
as to the state of the muscles in the jaw. If the opposite is true, where the MeCP2
dysfunction affects INa without any compensation from IH, these neurons would be
extremely hyperexcitable. Even with the compensatory mechanisms described here,
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there is still some hyperexcitability. However, if the reduction in IH did not occur, then the
impact of the alterations in INa would likely be much worse than seen here.
It must be considered whether the compensatory mechanisms described in this
thesis may be occurring in other neurons. It is unclear how the mechanisms underlying
the neuroadaptations are manifested. However, it seems that the changes in ion
channel and receptor expression from Mecp2-/Y mice depend on the specific function of
the neuron. For instance, LC neurons do not display a PIR or IH but do have a
decreased threshold. It is unclear why the altered threshold occurs in LC neurons. It is
unlikely to be directly caused by the MeCP2 defect and may be due to some unknown
reason. Alterations in ionic currents, other than the ones studied here, may be occurring
to maintain the function of neurons depending on a specific need.
Evolutionary considerations
Evolution seems to have occurred in such a way that a given function may be
produced by more than one protein that serves the same or similar purpose. This known
evolutionary conservation is interesting because there is strong evidence suggesting
that the ionic current density can vary greatly but without changing the neuron activity.
For example, in central pattern generators the density of various membrane currents in
neurons is not the same from cell to cell (Prinz et al. 2004). However, the rhythmic
pattern generated in these neurons is quite consistent. It seems that the density of
specific currents may not be kept at a fixed level within a neuron. Rather, there are
many combinations of current densities that are available to the neuron to keep it
functioning properly. The latter enables dynamic regulation as well as a better tolerance
of unexpected variation in ion channel activity. As a result, the firing activity is
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maintained, even though the many currents underlying the firing properties such as
threshold, resting membrane potential, interspike interval, PIR, etc. may change within
the neurons.
Degeneracy of ionic currents
In order for the many currents in a neuron to regulate the same firing property,
the underlying channels must have some common features. Evolution has created a
couple of different ways for this to be possible. The premise of degeneracy of ionic
currents fulfills this role. Degeneracy refers to the fact that multiple currents underlie
specific features of neuronal firing properties. One way is to simply have multiple
channels from the same family. For instance, IH is mediated by four different HCN (1-4)
channels. As we show here, If HCN2 expression is altered, then HCN1 can be
upregulated to replace it. In another way, pairs of currents are correlated with the
magnitude of a firing feature. In dopaminergic neurons, IH and IA are covaried in such a
way as to maintain the PIR (Amendola et al. 2012). The first current in the pair may be
altered and homeostatic compensation by the change in the second current maintains
proper firing. Homeostatic compensation has been well studied in the invertebrate
pyloric network of the stomatogastric ganglion in decapods. The pyloric network
features a stereotypical triphasic rhythm that is very robust despite the differences in
ionic currents from animal to animal. Similar to the study in dopaminergic neurons, the
interburst interval is regulated by IH and IA in the pyloric network. When IA is increased,
the expected increase in the interburst interval is not seen. This is because of a
compensatory increase in IH (MacLean et al. 2003). There are other pairs of ionic
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currents that underlie other bursting feature in these neurons (Zhao and Golowasch
2012).
Ionic currents change depending on the presence of modulatory input
The presence of neuromodulatory input seems to regulate the magnitude of the
ionic currents. When the modulatory input to pyloric neurons is blocked, the current
magnitudes change and become deregulated (Khorkova and Golowasch 2007). The
removal of the modulatory input causes the pyloric rhythm to be lost. However, the
rhythm will return because of the upregulation of specific genes (Thoby-Brisson and
Simmers 2000). This type of response indicates that the ionic currents are configured in
one way when the modulatory input is present. The ionic currents can be reconfigured
when the modulatory input is not present so the network starts bursting again. It is
unclear how the ionic currents are reconfigured exactly. It does seem likely that this is
able to occur because multiple currents can regulate many of the same firing features.
Therefore, these data reinforce the premise that stable neuron activity is made possible
by the degeneracy of ionic currents
Protein expression from cell to cell and animal to animal
The magnitude of membrane currents has been shown to be directly correlated
with the mRNA levels in a neuron (Baro et al. 1997; MacLean et al. 2005). Further, the
expression of the mRNA from different pairs of ion channels has been correlated with
firing features that have been well characterized electrophysiologically (Schulz et al.
2006; Tobin et al. 2009). These studies indicate that the alteration of currents is
because there are changes in protein expression levels. We see this in our studies as
well. The alteration of the receptors and ion channel expression patterns underlie the
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differences in the currents. The whole cell nAChR current in LC neurons from WT has a
large peak amplitude and a short decay time whereas the opposite is true in Mecp2-/Y
mice. In these mice, the peak amplitude is small and the decay time is long. Therefore
the modulation of LC neurons is preserved. The alteration in the voltage-gated Na+
channels changes the threshold by ~5mV. This seems to be done because the PIR is
~5mV less. Therefore, the changes in mRNA levels in Mecp2-/Y mice are done to
preserve neuronal firing properties just as it is done in normal animals.
Similarities between WT animals and animal models of disease
To determine if homeostatic compensation is a general mechanism among
neurons in Mecp2-/Y mice, we examined two different neurons and two different types of
ion channels that underlie the breathing abnormalities and movement problems.
Dysfunction in LC neurons from Mecp2-/Y mice seems to contribute to the breathing
problems in RTT. We found that the synaptic modulation through nAChRs is maintained
because of the reorganization of the receptor subunits. In the Me5 propriosensory
neurons we have found that membrane ionic currents are altered in such a way that
preserved normal function to some extent. These changes in the membrane ionic
currents can be attributed to the reorganization of the voltage-gated channel subunits.
Therefore, it does seem that the homeostatic compensation of ion channels is a general
mechanism in place to limit abnormal neuron activity.
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Conclusion
This dissertation attempts to address two specific aims that ask questions
regarding how neurons are able to remain viable despite the dysfunction of a crucial
protein. To answer these questions, we took advantage of a mouse model where
exons 3 and 4 of the Mecp2 gene were knocked out. In the first specific aim we
elucidated the modulation of LC neurons by ACh in Mecp2−/Y mice. We found that the
nAChR expression was altered to maintain normal cholinergic modulation of LC
activity. Secondly, we found that the cholinergic modulation of GABA input to the LC
was enhanced in Mecp2−/Y mice. In our second aim, we found that INa and IH were
changed in Mecp2−/Y mice. The alteration in the expression of the channels that
mediate these currents seems to underlie the differences.
The importance of these findings is that compensatory mechanisms are in place
in neurons from diseased animals. Specifically, the changes in expression levels of
receptors and ion channels can be modified to maintain a functional neuron. In some
cases this may be very precise, as seen in cholinergic modulation of LC neurons. In
others, the alterations may have deleterious effects such as the hyperexcitability found
in Me5 neurons from Mecp2−/Y mice. Furthermore, this dissertation provides a basis for
those who may be interested in finding ways to enhance what the body is doing
naturally to thwart the problems caused by the MeCP2 deficiency.
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